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1Abstract
This Thesis describes isolation and molecular
studies of mammalian erythrocyte nucleoside
transporters. Nitrobenzylthioinosine (NBMPR), a potent
inhibitor of nucleoside transport, binds tightly (Kd=
0.1-1 nM), but reversibly to specific sites on the
carrier mechanism. Data presented in Chapter 2
demonstrate that NBMPR can also be used as a covalent
probe of the system. High intensity UV irradiation of
intact human erythrocytes, isolated 'ghosts' and
protein-depleted membranes in the presence of [3H]NBMPR
and dithiothreitol (DTT) (added as a free radical
scavenger) under both nonequilibrium and equilibrium
binding conditions resulted in selective covalent
incorporation of 3H into the band 4.5 region of sodium
dodecyl sulphate (SDS)-polyacrylamide gels (Mr= 45,000-
66,000). Covalent labelling with[ 3H]NBMPR of band 4.5
Protein(s), which have been previously implicated in
human erythrocyte glucose transport, was inhibited by
nitrobenzylthioguanosine (NBTGR), dipyridamole, uridine
and adenosine. A similar photolabelling pattern was
observed using membranes from pig erythrocytes, cells
which lack glucose transport activity. In contrast, no
incorporation of radioactivity into the band- 4.5 region
was observed under equilibrium binding conditions with
membranes prepared from nucleoside-impermeable sheep
erythrocytes. These experiments strongly suggest that
2the human and pig erythrocyte NBMPR binding proteins are
band 4.5 polypeptides, a conclusion supported by the
isolation studies described in Chapter 3 where the pig
erythrocyte nucleoside transport protein was purified
140-fold by treatment of haemoglobin-free 'ghosts' with
EDTA (pH 11.2) to remove extrinsic proteins followed by
extraction of the protein-depleted membranes with octyl
glucoside and subsequent gradient-elution ion-exchange
chromatography on DEAE-cellulose. SDS-polyacrylamide gel
electrophoresis of the purified material revealed the
presence of only two detectable protein bands, one which
co-migrated with the radiolabelled NBMPR-binding
protein, and a lower molecular weight species with an Mr
of 43,000. The overall purification of the NBMPR-binding
protein with respect to the Mr 64,000 band., was 350-fold.
Reversible NBMPR-binding to the partially-purified pig
band 4.5 preparation was saturable (apparent Kd= 7.2
nM). Adjustment of the chromatography conditions to
allow elution of the NBMPR-binding protein along with
the majority of solubilised membrane phospholipid
reduced this apparent Kd value to 3.0 nM. Purification
of reversible NBMPR-binding activity during ion-exchange
chromatography was paralleled by an increase in the
specific activity of NBTGR-sensitive uridine transport
as assayed in proteoliposomes reconstituted by a
freeze-thaw-sonication procedure.
The human erythrocyte nucleoside and glucose
3transporters were found to co purify during DEAL-
cellulose ion-exchange chromatography. Partially-
purified nucleoside and glucose transport proteins (band
4.5 polypeptides) isolated from human erythrocyte
membranes were photolabelled with[ 3H]NBMPR and[ 3'H]-
cytochalasin B, respectively, and subjected to endo-p-
galactosidase or endoglycosidase- F digestion (Chapter
4). Without enzyme treatment the two radiolabelled
transporters migrated on S DS -polyacrylamide gels with
same apparent Mr (average) of 55,000. Apparent Mr
(average) values after endo-B-galactosidase digestion
were 47,000 and 48,000 for the nucleoside and glucose
transporters, respectively, and 441000 and 45,000,
respectively, after endoglycosidase-F digestion. In
contrast, endo-p-galactosidase had no effect on the
electrophoretic mobility of the nucleoside transporter
isolated from pig erythrocytes. This transport system
exhibited a significantly higher Mr than the human
protein, endoglycosidase-F treatment decreasing its
apparent Mr (average) from 64,000 to 57,000. It is
concluded that the human and pig erythrocyte nucleoside
transporters are glycoproteins containing N-linked
oligosaccharides. The data provide evidence of
substantial carbohydrate and polypeptide differences
between the human and pig erythrocyte nucleoside
transporters, and evidence of very general molecular
similarities between the human erythrocyte nucleoside
and glucose transporters.
4The transmembrane topology of the [3H]NBMPR-
labelled human and pig erythrocyte nucleoside
transporters was investigated by monitering the effects
of proteinases applied to right-side-out vesicles (ROVs)
and unsealed membranes (Chapter 5). Limited digestion of
ROVs with trypsin had no effect on the apparent
molecular weight of the human and pig transporters.
Cleavage sites were, however, present on the inner
membrane surface, since similar treatment of unsealed
human and pig membranes yielding broad radioactive
fragments of apparent Mr (average) 38,000 and 42,000,
respectively, these fragments migrated as broad bands on
gel electrophoretograms. Endoglycosidase-F digestion of
these tryptic fragments produced sharper radioactive
peaks and shifted them to lower molecular weight regions
of the gel (apparent Mr (average) 30,000 for human and
37,000 for pig). It is therefore concluded that these
fragments contain carbohydrate. Chymotrypsin cleaved the
human and pig nucleoside transporters from both sides of
the membrane, whereas thermolysin only cut the exofacial
domains of the transporters. Finally, it was observed
that treatment with N- and C-terminal peptidases did not
generate significant movement of the band 4.5
radioactive peak in either species, suggesting that the
transporter N- and C-terminals are blocked, puried in
the membrane or contain amino acids that are not
hydrolysed by the enzymes studied. Alternatively, and
perhaps more likely, small segments may have been
5removed from the terminals, the changes in apparent Mr
being too small to be detected by SDS-polyacrylamide gel
electrophoresis.
The results from these proteolytic cleavage
studies suggest that the main difference between the
human and pig erythrocyte nucleoside transporter
polypeptides could be due to the presence of an extra
segment in the mid-region of the pig transporter. The
general molecular structure of the human erythrocyte
nucleoside transporter appears similar to that of the
human glucose transporter (Chatper 7).
Monoclonal antibodies (MAbs) were raised against
the partially purified pig erythrocyte nucleoside
transporter preparation in a joint venture with the
Cancer Research Group, McEachern Laboratory, University
of Alberta. MAb 3E3 protein, linked to derivatised
agarose gel beads (Affi-Gel 10, Bio-Rad) was used in
purification of the pig nucleoside transporter (Chapter
6). In a parallel series of experiments, MAb GTRP-1,
specific for the human erythrocyte glucose transporter,
was coupled to Affi-Gel 10 to prepare an immunoadsorbant
column and used to achieve chromatographic separation of
the human erythrocyte nucleoside and glucose transporter
proteins (Chapter 6).
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Nucleosides have a multitude of biochemical and
physiological effects (Harmon et al., 1978 Walker et
al., 1979 Berne and Rubio, 1983). In addition,
nucleoside analogues are widely used as therapeutic
agents for neoplastic and viral diseases in man and to a
lesser extent as anti-parasitic agents (Suhadolnik,
1979). However, before the above biological effects of
nucleosides and their analogues are initiated, these
compounds have generally to be transported out of or into
cells. Thus, nucleoside translocation across cell
membranes is an important determinant of the biological
activity of nucleosides and nucleoside drugs. Hence,
there is considerable interest in the mechanisms
resposible for nucleoside transport across biological
membranes. Most studies to date have been concerned with
the kinetic properties, specificity and inhibitor
susceptibility of nucleoside transport mechanisms. At the
time the present project was initiated, there was little
information on the molecular properties of the membrane
components responsible for nucleoside transport.- The
objectives of my experiments were to identify, solubilise
and purify nucleoside transporter polypeptides from
mammalian erythrocytes.
In the context of the present project there have
been three important milestones in nucleoside transport
research. The first was the discovery by Paterson and
co-workers that NBMPR was a potent and specific
2reversible inhibitor of nucleoside transport in
erythrocytes and a wide variety of other cell types and
tissues (see e.g. Oliver and Paterson, 1971 and Paterson,
et al., 1983). The second was the demonstration by Jarvis
and Young .(1980) that the human erythrocyte nucleoside
transporter could be purified 13-fold by DEAE-cellulose
ion-exchange chromatography. This purification was based
on the assay of reversible NBMPR binding activity and was
the first study to implicate band 4.5 polypeptides (Mr
45,000-66,000) in erythrocyte nucleoside permeation.
Finally, in 1983, Young et al., developed conditions
which permitted NBMPR to be used as a covalent probe of
the human erythrocyte nucleoside transporter.
The immediate aim of the present study was to
investigate in detail the photolabelling of human
erythrocyte membranes by[ 3H]NBMPR and to compare the
labelling pattern obtained with that given by membranes
from other species. These studies identified the NBMPR
binding protein as a band 4.5 polypeptide and established
conditions for the use of NBMPR as a specific covalent
probe of nucleoside transporter polypeptides. 'This
covalent labelling technique was subsequently exploited
in experiments to solubilise and partially purify the pig
erythrocyte nucleoside transporter by ion-exchange
chromatography. The degree of purification achieved
(140-fold) was a considerable improvement over that
obtained by. Jarvis and Young, (1981) using human
erythrocyte 'membranes. The partially-purified pig
3erythrocyte nucleoside transport protein was subsequently
used as immunogen for monoclonal antibody production by
Good et al., (1986) at the M c E achern Laboratory,
University of Alberta, Canada, see Good etal. (1986) for
details). These antibodies were subsequently employed in
preliminary studies aimed at developing an alternative
immunoaffinity procedure for the purification of the pig
erythrocyte nucleoside transporter. In a parallel series
of experiments, monoclonal antibodies specific for the
glucose transporter were used to achieve the chromato-
graphic separation of the human erythrocyte nucleoside
and glucose transporters (experiments carried out in
collaboration with Dr. S.A. Baldwin of the Departments of
Biochemistry and Chemistry, and of Chemical Pathology and
Human Metabolism, Royal Free Hospital School of Medicine,
London, England and the Paterson Laboratory, Christie
Hospital, Mancherter, England).
Photoaffinity labelling with NBMPR was also used to
investigate the molecular differences between the human
and pig erythrocyte nucleoside transporters and molecular
similarities between the human erythrocyte nucleoside and
glucose transporters. The transmembrane topology of the
human and pig nucleoside transporter was also
investigated.
The major section of the present Chapter is a brief
review of the literature on nucleoside transport in
animal cells. This is followed. by a description of the
4experimetal strategy adopted in the present investigation
and its aims. Finally, the organisation of the remainder
of the Thesis is outlined.
1.2 Physiological and pharmacological importance of
nucleosides
Nucleosides have diverse physiological and
biochemical actions. Adenosine, for example, modulates
vascular tone, neural function, platelet aggregation and
lymphocyte differentiation (Harmon et al., 1978 Walker
et al., 1979 Berne et al., 1983). Its mechanism of
formation has. led to the suggestion that adenosine
functions as a novel form of cellular regulator for which
the term retaliatory metabolite has been proposed
(Newby, 1984). Before the start of this study, inosine
was postulated to be an in vivo energy source for pig
erythrocytes, cells which are unable to metabolise plasma
glucose (Jarvis et al., 1980b Kim et al., 1980). This
was subsequently proved to be correct (Young et al.,
1985, 1986 Zeidler et al., 1985). Adenosine is also a
physiological precursor of erythrocyte ATP in man
(Valentine et al., 1977). Cytotoxic nucleosides have
established or potential uses as therapeutic agents for
the treatment of human neoplastic and viral disease
(Walker et al., 1979 De Clercq et al., 1980 dauri et
al., 1981 Tattersall and Fox, 1981 De Clercq, 1984). Of
various cytotoxic nucleosides with clinical application
as antineoplastic agents, the best known is cytosine
5arabinoside which is an esential part of the current
treatment of acute myeloid leukaemia (Wiemik 1980; Hess
and zirkle, 1980). As well, 5-azacytidine has established
clinical applications. Several nucleoside derivatives,
notably acyclovir, are effective inhibitors of the
proliferation of DNA viruses (De Clercq et al., 1980 De
Clercq, 1984) and 3'-azido-3'deoxythymidine has potential
theraputic application in the treatment of aquired
immunodeficiency syndrome (see Nature (1987), vol. 325,
p564). Nucleoside analogues may also have application in
the chemotherapy of parasitic infections (el Kouni etal.,
1983, 1986). Each of these actions of nucleosides and
nucleoside analogues require their transport either into
or out of cells.
The coronary vasodilator effects of dipyridamole,
dilazep, hexobendine and lidoflazine are appeared to be
mediated through their actions as adenosine transport
inhibitors (Berne et al., 1983), while NBMPR is an in
vivo inhibitor of pig erythrocyte energy metabolism
(Young et al., 1986). Similarily, the nucleoside
transport capacity of target cells and the
'transportability' of a nucleoside analogue, that is its
acceptability as a substrate for the nucleoside
transporter, are important determinants of cytotoxicity.
For example, measurements of NBMPR binding capacity are
likely to prove useful in assessing the therapeutic
potential of arabinosibe C in human acute- leukaemias
(Wiley et al., 1985).
61.3 Transport of nucleosides by animal cells
1.3.1 Kinetic studies
The entry (and efflux) 'of nucleosides into animal
cells is mediated by nucleoside- specific transport
elements in the plasma membrane (Plagemann and
Wohlhueter, 1980 Paterson et al., 1981 Young and
Jarvis, 1983). The substrate specificity of the
nucleoside transport machinery in human erythrocyte is
very broad in that a single type of transport mechanism
mediates entry of (i) the physiological nucleosides
(purine or pyrimidine ribosides and deoxyribo-
nucleosides), and (ii) a variety of nucleoside
derivatives with very diverse nucleobase moieties.
2-Chloroadenosine, once thought to be a non-transported
inhibitor of nucleoside transport, has now been shown to
be a good substrate for the human erythrocyte nucleoside
transporter (Jarvis et al., 1985). Recent studies
indicate that nucleoside transporters from some cell
types may, in addition, exhibit a significant affinity
for free nucleobases (Slaughter et al., 1981 Plagemann
and Wohlheuter. 1984a). Nucleoside transport is a rapid,
reversible, non-concentrative 'facilitated-diffusion'
process in erythrocytes and in, cultured cells of various
types (Cabantchick and Ginsberg, 1977 Wohlhueteret al.,
1979a Harley et al., 1982 Jarvis et al., 1983a). The
kinetic properties of the human erythrocyte system are
consistent with a simple carrier mechanism (Cabantchik
7and Ginsburg, 1977; Jarvis etas., 1983a; Lieb etal.,
1982; Young and Jarvis, 1983). The carrier is
directionally symmetrical in erythrocytes from fresh
blood, but directionally asymmetrical in cells from
outdated blood (Jarvis et al., 1983a). This kinetic
difference between nucleoside transport in fresh blood
and outdated erythrocytes is attributed to differences in
the mobility of the unloaded carrier and is accentuated
at low temperature (Jarvis and Martin, 1986; Plagemann
and Wohlhueter, 1984b). Transport of nucleosides in HeLa
and Novikoff rat hepatoma cells also conforms to the
simple carrier model (Wohlhueter et al., 1979a;
Wohlhueter and Plagemann, 1982). However, nucleoside
transporters in erythrocytes and cultured cells differ
significantly in their translocation capacities (Young
and Jarvis, 1983).
Results of early studies demonstrating that
nucleoside uptake by cultured cells could be modified by
a variety of factors including hormones and cyclic
nucleosides (see e.g. Plagemann and Richey, 1974) can be
attributed to effects on intracellular nucleoside
phosphorylation rather than on transport per se (Koren
et al., 1978; Rozengurt et al., 1978; Wohlhueter et al,
1979b). Physiological regulation of nucleoside transport
activity does, however, occur during reticulocyte
maturation. This 'down regulation' of nucleoside
transport activity during reticulocyte maturation is
restricted to certain species (e.g. sheep but not pig or
8human) and may involve release trom the cel.L o
transporter polypeptides in vesicluar from (Johnstone
et al., 1985).
Recent studies by Schwenk et al. (1984) and Jakobs
and Paterson• (1986) have demonstrated the presence of
sodium-dependent nucleoside transport mechanisms in
guinea pig intestinal epithelial cells and cultured rat
intestinal epithelial cells, respectively.
1.3.2 Inhibitor studies
NBMPR and certain related S -derivatives of 6-thio-
urine nucleosides are very potent, reversible inhibitors
Df nucleoside transport in a wide variety of cell types
and tissues (Paterson et al., 1981 Young and Jarvis,
1983). Inhibition of transport correlates with occupancy
by these inhibitors of high-affinity binding sites on the
transporter of human erythrocytes (Cass et al., 1974).
Dissociation constants for specifically-bound NBMPR at
these sites in erythrocytes and cultured cells are in the
order of 0.1- 1.OnM (Cass et al., 1974 Javis and Young,
1980 Cass et al., 1981 Dahlig-Harley et al., 1981
Jarvis et al., 1982a Plagemann and Wohlhueter, 1984a,
1985). A direct proportionality between binding site
occupancy by NBMPR and fractional inhibition of uridine
transport in human erythrocytes has been demonstrated
(Cass et al., 1974), and instances have been described' in
which absences of nucleoside-. transporter activity in
erythrocytes and in cultured cells were characterised by
9the corresponding absences of site-specific binding of
NBMPR (Jarvis and Young, 1980 Cass et al., 1981). As
well, in erythrocytes from various species, the maximum
cellular transport capacity (Vmax) for uridine was found
to be directly related to the number of membrane
transporter elements (NBMPR binding sites) present in
each of the cell types studied (Jarvis and Young, 1980,
1982 Jarvis et al., 1982b). Together these findings are
the basis of the concept that the site-specific,
high-affinity binding of NBMPR takes place on functional
nucleoside transporter elements of erythrocytes and
various nucleated cell types however, exceptions have
been reported (see below). High-affinity NBMPR binding
sites in red cell ghosts have been employed in
radiobinding. assays of plasma concentrations of
nucleoside transport inhibitors (Clanachan and Serignese,
1985 Young et al., 1986).
A new and important perspective on nucleoside
transport has been provided by the recent recognition of
the existence of low (IC50 1 uM) NBMPR-sensitive
nucleoside transport mechanisms in several lines* of
neoplastic cells. For example, the Walker 250 rat
carcinosarcoma and the Novikoff rat hepatoma have
nucleoside transporters insensitive to nanomolar
concentrations of NBMPR (Wohlhueter et al., 1978 Belt
1983a Paterson et al., 1983), while other cultured
neoplastic cells such as L1210, L5178Y and P388 murine
leukaemia cells, transformed hamster fibroblasts and HeLa
10
cells exhibit both NBMPR-sensitive and NBMPR-insensitive
transport (Dahlig-Harley et al., 1981 Belt 1983a,b
Eilam and Cabantchik, .1977 Plagemann and Wohlhueter,
1985). NBMPR-insensitive transport has been exploited in
an experimental chemotherapeutic strategy in which high,
potentially lethal doses of cytotoxic nucleosides are
co-administered with host-protective doses of NBMPR
5'-phosphate (a soluble 'prodrug' form of NBMPR) (Lynch
et al., 1981a,b el Kouni et al., 1983). The finding that
some normal tissues also exhibit NBMPR-insensitive
transport may limit the usefulness of this approach
(Plagemann and Wohlhueter, 1985 Jarvis and Young, 1986
Wu et al., 1986).
1.3.3 Mechanism of interaction of inhibitors with
nucleoside transport systems
NBMPR, dipyridamole and, to a lesser extent, dilazep
are widely used in physiological, pharmacological and
biochemical studies of nucleoside transporter function.
However, the mechanism(s) by which these inhibitors
interact with the nucleoside transporter is unclear and
the subject of some debate.
Kinetically, NBMPR is an apparent competitive
inhibitor of zero-trans uridine influx and equilibrium-
exchange in guinea pig and nucleoside-permeable sheep red
blood cells, but a non-competitive inhibitor of uridine
zero-trans efflux (Jarvis et al., 1982c Jarvis, 1986b).
On the other hand, nucleosides are competitive inhibitors
11
of erythreeyte NBMPR-bindeng (jarvis et al, 1982c;
1983b). Agbanyo et al., (1986) have provided evidence
that the NBMPR-binding sites of pig erythrocytes are on
the outer surface of the membrane, a suggestion supported
by the kinetic studies of Jarvis et al. (1982c). Such
results are consistent with a simple model in which NBMPR
inhibits nucleoside transport by binding selectively to
the outward-facing conformation of the substrate
permeation site, this binding being stabilised by the
interaction of the nitrobenzene ring with an adjacent
hydrophobic domain on the transporter (Jarvis and Young,
1982 Young and Jarvis, 1983). Kinetically, dipyridamole
inhibits nucleoside transport in the same way as NBMPR
and the two ligands bind to the transporter with the same
stoichiometry- (Jarvis, 1986b Shi and Young, 1986).
Furthermore, nucleosides are competitive inhibitors of
dipyridamole binding and vice versa (Hammond etal., 1981
Jarvis, 1986b Shi and Young, 1986). These results
suggest that dipyridamole and N B M P R interact at common
or overlapping sites on the carrier.
These results suggested that NBMPR binds to 'the
permeation site, and a model of NBMPR binding and
nucleoside permeation was proposed by Jarvis and Young
(1982). However, this model does not reconcile with a
number of observations. (a) Walker 259 cells have no
NBMPR binding sites but transport nucleosides, (b) the
presence of both high afinity- NBMPR binding sites and
NBMPR-insensitive transport systems in cultured rat
12
hepatoma cells, and (c) genetics experiments by Ullman
and Cohen showed that the expression of NBMPR binding
activity in S49 mouse lymphoma cells may be altered by
mutation independently of nucleoside transport activity
(Cohen et al., 1979 Cass et al., 1981 Aronow et al.,
1986 Gati et al., 1986). A final answer to this
important question will only come with the isolation and
complete molecular characterisation of the transporter.
1.4 Molecular properties of the nucleoside transporter
This section details studies published prior to, or
at the start of the present investigation. Subsequent
publications in this area are cited as appropriate in
subsequent Chapters.
The development of NBMPR and related compounds as
specific high-affinity probes of the nucleoside trans-
porter has allowed rapid recent progress in studies of
the molecular properties of the carrier. The protein
nature of the transporter has been formally demonstrated
by studies of the effects of proteases and organo-
mercurials on NBMPR binding and nucleoside transport
(Jarvis and Young, 1982 Heichal et al., 1978 Bibi
et al., 1978 Paterson et al., 1980). In erythrocytes,
trypsin and p-chloromercuribenzene sulphonate (PCMBS)
inhibit NBMPR-binding activity but this only occurs in
broken membranes and is not observed in intact cells,
suggesting that the trypsin and PCMBS-sensitive sites are
13
located on the inner surf ace of the cell membrane (Jarvis
and Young, 1982). The human erythrocyte nucleoside
transporter therefore exhibits chemical asymmetry.
Using high-affinity N B M P R-binding activity as an
assay for the carrier, a 13-fold purification of the
transporter from human erythrocyte ghosts was achieved by
means of detergent extraction and subsequent ion-exchange
chromatography on DEAE-cellulose (Jarvis and Young,
1981). The partially-purified preparation contained two
protein bands detected by SDS-polyacrylamide gel
electrophoresis: band 4.5 and a trace of band 7
(nomemclature of Steck (1974)). The glucose transport
system of human erythrocytes has also been shown to be a
band 4.5 polypeptide, the nucleoside and glucose
transporters- (10 and 10 copies per cell,
respectively), co-migrating on SDS-polyacrylamide gels
with the same apparent molecular weight. The two
transporters also co-purified during DEAE-cellulose
ion-exchange chromatography (Jarvis and Young, 1981
Baldwin et al., 1981, 1982). As a result, partially-
purified band 4.5 preparations from human erythrocytes
consist largely of glucose transporter, with the
nucleoside transporter present as a minor component. The
ratio of glucose/ nucleoside transporters in
partially-purified band 4.5 preparations from human
erythrocytes has been estimated to be in the region of
20:1 (Jarvis and Young, 1981-. Baldwin et al., 1982).
Therefore, further purification of the human erythrocyte
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nucleoside transporter requires its separation from the
glucose transport protein.
The glucose transporter from human erythrocytes is a
glycoprotein that is about 15% carbohydrate by weight
(Sogin and Hinkle, 1978) and heterogeniety has been
demonstrated in the structure of the oligosaccharide
chain (or chains) linked to the transporter polypeptide
(Gorga et- al., 1979). Apparently because of this
heterogeniety, the purified human erythrocyte glucose
transporter migrates as a diffuse band in the band 4.5
region of SDS-polyacrylamide gels (Baldwin et al., 1982).
The use of NBMPR and its analogues as tightly bound
probes of the nucleoside transporter is complicated by
the reversible nature of their binding to the transport
protein. The- situation is further complicated by the
finding that some non-ionic detergents are potent
inhibitors of NBMPR binding (Cass et al., 1974 Jarvis
and Young, 1980, 1981 Jarvis et al., 1983a Koren
et al., 1983). To overcome these limitations, a
photoaffinity analogue of NBMPR,[ 3H]N-(p-azidobenzyl)
adenosine (ABA) was tested by Young et al., (1983) for
its ability to photoaffinity label the human erythrocyte
nucleoside transporter. In the same series of
experiments, NBMPR was also shown to become covalently
link-to its binding site simply by exposure of site-bound
NBMPR to high-intensity UV light (Young etal., 1983).
These results demonstrated that photoactivation of
membrane-bound[ 3H]ABA and[ ]NBMPR in the presence of
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dithiothreitol (DTT) as a free radical scavenger resulted
in selective incorporation of radioactivity into band 4.5
proteins, providing further evidence to implicate this
class of membrane polypeptides (apparent molecular weight
45,000-66,000) in nucleoside permeation. An earlier study
(Rosenblit and Levy, 1980) reported that a plasma-
membrane polypeptide of similar apparent molecular weight
(56,000) was selectively labelled upon exposure of adipo-
cyte membranes to 8-azido[ H]adenosine, a photolabile
transported nucleoside. Interference with photoactivated
covalent binding of radioactivity from the adenosine
derivative by other transported nucleosides and
dipyridamole was the basis of relating the labelled
protein to the nucleoside carrier. However, the
interpretation of these adipocyte experiments is
complicated by the recent demonstration that the glucose
transporter and not the nucleoside transporter is the
site of radiolabelling by 8-azido[3H]-adenosine in human
erythrocytes (see General Discussion).
There is little doubt that nucleoside and glucose
transport are catalysed by separate membrane proteins.
For example, monoclonal antibodies raised against the
glucose transport protein do not cross-react with the
nucleoside transport protein (Boyle et al., 1985) and
inhibitors of glucose transport have no effect on
nucleoside permeation and vice versa (Oliver and
Paterson, 1971). Nevertheless, the two transporters share
a number of common properties (Cabantchik and Ginsburg,
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1977 Jarvis and Young, 1982a Widas, 1980) and it has
been suggested that they may be structurally similar
(Jarvis and Young, 1980 Young et al., 1983). Radiation-
inactivation analyses of reversible NBMPR-binding
activity estimate that the human erythrocyte nucleoside
transporter has an in situ molecular weight of 120,000,
suggesting that the carrier may exist in the membrane as
a dimer (Jarvis et al., 1980 1984 1986).
1.5 Pig erythrocyte energy metabolism
Erythrocytes from new-born pigs possess a functional
glucose transport system (Zeidler et al., 1976 Kim and
Luthra, 1977) and consequently are permeable to hexoses.
These fetal cells are able to use plasma glucose as an
energy substrate (Kim et al., 1973), but are replaced by
glucose-impermeable adult erythrocytes within 1 month
after birth. The adult cells, unlike erythrocytes from
many other mammalian species, cannot metabolise glucose,
despite the presence of all the necessary enzymes and
co-factors (Kim and McManus, 1971a,b). There has been
considerable speculation as to the identity of the energy
substrate used by these cells. A number of candidates
have been proposed, including inosine, adenosine, ribose
deoxyribose, dihydroxyacetone and glyceraldehyde (Zeidler
et al., 1976 Kim and McManus, 1971a, b Widdas, 1955
Kirschner, 1964 Rivkin and Simon, 1965 McManus, 1967
McManus and Kim, 1968). With the exception of
dihydroxyacetone (McManus, 1974), these compounds have
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only been studied at unphysiological concentrations in
the millimolar range. Young et al. (1985) have provided
in vitro evidence that physiological plasma inosine
concentrations (-2 uM) are sufficient to maintain ATP
levels in erythrocytes from the Yucatan miniature pig and
it was subsequently shown that NBMPR functions as an in
vivo inhibitor of pig erythrocyte energy metabolism, the
inhibitor blocking inosine entry into the cell (Young
et al., 1986). Thus, the physiological role of the
nucleoside transporter in pig erythrocytes is, to provide
ribose phosphate for intracellular glycolysis. This
inosine is derived from the liver (Kim et al., 1980). The
functional absence of a glucose transporter from pig
erythrocytes provides genetic evidence that glucose and
nucleoside transport are mediated by separate membrane
polypeptides (see previous section).
1.6 Experimental strategy and objectives
The overall objective of this study was to purify an
erythrocyte nucleoside transporter. Since the partially-
purified human nucleoside transporter preparation of
Jarvis and Young (1981) consisted largely of glucose
carrier, further purification of the nucleoside
transporter in this species requires its separation from
the glucose transport protein. Conventional fractionation
techniques such as electrophoresis, iso-electric
focusing, ion-exchange chromatography and affinity
chromatography using lectins might be anticipated to be
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useful in this context. A complimentary approach, and the
one adopted in the present study, is that of exploring
ion-exchange chromatography conditions for isolation of
the nucleoside transporter from erythrocytes of the pig.
Pig erythrocytes exhibit high-affinity NBMPR-binding
activity (5,000 sites per cell) and are capable of rapid
NBTGR-sensitive nucleoside transport (Jarvis et al.,
1980b). However, in contrast to human erythrocytes, these
cells lack cytochalasin B-sensitive glucose transport
activity (Kim and -McManus,, 1971 Zeidler et al., 1976)
and are therefore anticipated to be- deficient with
respect to the major band 4.5 polypeptide present in
human erythrocytes (Young and Jarvis, 1982 Wagner
et al., 1984).
In these studies, photoaffinity labelling with
radiolabelled NBMPR was used to facilitate detection of
the solubilised nucleoside transport protein. The first
series of experiments were therefore directed towards
establishing the validity of using NBMPR as a covalent
probe of the erythrocyte nucleoside transporter. In the
course of the studies, it was established that the human
and pig erythrocyte nucleoside transporters have
significantly different apparent molecular weights on
S DS -polyacrylamide gels. The origin of this molecular
weight difference and the glycoprotein nature of the
transporters were studied using partially-purified
nucleoside transporter preparations. The same -series of
experiments were also designed to further explore
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molecular similarities between the human erythrocyte
nucleoside and glucose transporters. Using several
proteolytic enzymes, the transmembrane topology of the
human and pig erythrocyte nucleoside transporters were
also investigated. Finally, attempts were made to develop
the monoclonal antibody immunoaffinity chromatography
method for further purification of the human erythrocyte
nucleoside transporter and its separation from the
glucose carrier protein. The feasibility of using
monoclonal antibodies to purify the pig erythrocyte
nucleoside transporter was also assessed.
1.7 Organisation of Thesis
The remainder of this Thesis is divided into six
Chapters. In Chapter Two, a detailed study of the photo-
affinity labelling of erythrocyte membranes by [3H]NBMPR
is presented. Conditions for photo-incorporation of [3 H]-
NBMPR into erythrocyte membranes are described and the
identity of the membrane polypeptides radiolabelled by
[3H]NBMPR is described.
Chapter Three describes conditions for the isolation
of the pig erythrocyte nucleoside transporter. This
Chapter also describes the characterisation of the
resulting preparation in terms of protein and lipid
content, protein composition, reversible NBMPR binding
activity and uridine transport activity.. Chapter Four
presents evidence that the human and pig erythrocyte
nucleoside transporters are glycoproteins and explores
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the origin of molecular weight differences between the
nucleoside transporters from these two species. Chapter
Four also demonstrates that the deglycosylated human
erythrocyte nucleoside and glucose transporters have
essentially identical apparent molecular weights as
determined by SDS-polyacrylamide gel electrophoresis.
Chapter Five further describes the molecular
properties and the transmembrane disposition of the human
and pig erythrocyte nucleoside transporters by treatment
of unsealed membranes and right-side-out membrane
vesicles with proteolytic enzymes.
Chapter Six explores the use of monoclonal antibody
immunoaffinity column chromatography to further purify
the human and pig erythrocyte nucleoside transporters.
Finally, Chapter Seven presents a general discussion of
the results presented in the preceeding Chapters. A
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2.1 Introduction
Jarvis and Young (1981) showed that Triton X-100
extraction of human erythrocyte membranes in combination
with DEAE-cellulose ion-exchange chromatography results
in substantial purification of NBMPR-binding activity.
The significance of this study was that the resulting
partially-purified preparation consisted largely of band
4.5 polypeptides, proteins previously implicated in
hexose transport. In subsequent experiments, a photo-
affinity analogue of NBMPR, ABA, was employed to label
the NBMPR-binding site of the carrier (Young et al.,
1983). Protein-depleted membranes were used in this study
to minimise the possibility of non-specific attachment of
ligand to extrinsic membrane proteins. Photoactivation of
site-bound [3-H]ABA in the presence of DTT as a free-
radical scavenger resulted in selective covalent
incorporation of radioactivity into band 4.5 poly-
peptides. The same series of experiments established that
[3 H]NBMPR could be photoactivated by exposure to UV
light, again resulting in selective labelling of the band
4.5 region of S D S- poly acrylamid a gels.
This chapter presents a detailed investigation of
the photoaffinity labelling of erythrocyte membranes by
[3 H]NBMPR. It is demonstrated that photoactivated [3H]-
NBMPR selectively labels band 4.5 in both intact human
erythrocytes and isolated membranes. Covalent attachment
of ligand to band 4.5 under equilibrium binding condit-
ions is inhibited by NBTGR, dipyridamole (a structurally
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unrelated nucleoside transport inhibitor), and the trans-
ported nucleosides, adenosine and uridine. It is further
demonstrated that photoactivated[ 3H]NBMPR covalently
labels band 4.5 protein(s) in membranes from pig erythro-
cytes, cells which transport nucleosides rapidly, but
which lack a functional glucose transporter (Kim and
McManus, 1971a, b Jarvis et al., 1980b). In contrast, no
detectable binding occured in membranes prepared from
nucleoside transport-deficient sheep erythrocytes. These
experiments provide additional strong evidence to
implicate band 4.5 membrane protein(s) (apparent






Fresh blood from healthy volunteers was withdrawn by
syringe into heparin (1000 units per ml blood).
2.2.1b
Whole blood from adult pigs was collected from the
jugular vein of animals slaughtered at the Cheung Sha Wan
Abattoir, Kowloon, Hong Kong. Heparin was again used as
anticoaulant.
2.2.Ic Sheep
Whole blood from adult sheep was collected by
jugular. venepuncture into heparinised syringes. The sheep
were maintained under standard husbandry conditions at
the Agriculture and Fisheries Department Research
Laboratories at Castle Peak, N.T., Hong Kong.
2.2.ld Cell Preparation
Erythrocyters were washed three times with 20
volumes of a medium containing 140 mM NaCl, 5 mM KC1, 20
mM Tris-HC1 (pH 7.4 at 25°C), 2 mM MgC1, 0.1 mM' EDTA




The haemoglobin content of cell lysates was
determined by absorbance measurments at 540nm using a
Varian 634 spectrophotometer. Cell volume was calculated
from experimentally determined extinction coefficients
for packed erythrocyte of 320, 299 -and 290 cm-1 for
human, pig and sheep erythrocytes, respectively.
2.2.2 Photoaffinity labelling studies
2.2.2a membrane preparation
Haemoglobin-free erythrocyte membranes (ghosts) were
prepared by osmotic lysis as described by Dodge et al.
(1963). One volume of packed cells were mixed with
approximately 20 volumes of 5 mM sodium phosphate (pH
8.0)(5P8) and left to stand for 20 min at 4°C. Ghosts
were pelleted by centrifugation at 30,0002 for 20 min
using a Beckman L2-21 centrifuge. The majority of
supernatant was removed, with an aliquot retained for
haemoglobin estimation (see Section 2.2.1e). The loosely
packed ghosts were then transfered to clean tubes, taking
care to leave behind the small hard button containing the
residual leukocytes and platelets not removed with the
buffy coat. The membranes were washed three times with 20
volumes of 5P8, made back to the original cell volume in
5P8 and stored at -70°C for up to 1 month. Protein was
Gai-armi n i by thg method of Lowrv (1970.
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2.2.2b Photoaffinity labelling of erythrocyte membranes
Erythrocyte ghosts (1.5-2.0 mg protein/ml, final
concentration) were equilibrated at room temperature for
30 min with a saturating concentration of [3H]NBMPR (75
nM) in the presence and in the absence of 20 uM NBTGR as
competing nonradioactive ligand. To -study photolysis in
the absence of unbound[ 3H]NBMPR (nonequilibrium condi-
tions), membranes were pelleted at 35,0008 for 15 min,
washed once with 40 volumes of ice-cold 5P8, and
resuspended in the same ice-cold buffer containing DTT
(usually 50 mM) to give the original protein
concentration. To study photolysis under equilibrium
binding conditions, membrane suspensions equilibrated
with 3H-ligand were simply cooled to 4'C and suplemented
with 50 mM DTT (final concentration). Previous control
experiments have shown that DTT does not interfere with
[3H]NBMPR binding (Jarvis et al., 1980).
Photolysis was carried out in conventional 3m1
silica spectrophotometer cuvettes (10 mm light path) with
continuous stirring at 4°C. Samples were exposed to high
intensity UV light from a 450-watt mercury arc lamp
(Canrad-Hanovia, Inc., Newark, NJ). Exposure was for 45 s
at a distance of 6.5 cm from the lamp's silica cooling
sleeve, unless otherwise stated. Samples were then
diluted 10-fold with 5P8 containing 10 uM NBTGR and
allowed to stand at room temperature for 10 min before
recovery of the membrane fraction by centrifugation. The
membrane pellets were washed twice more with NBTGR-
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containing buffer and dissolved either in 5% (w/v) Triton
X-100 for radioactivity determination or in gel electro-
phoresis buffer (see below).
2.2.2c Photoaffinity labelling of intact cells
In one series of experiments, freshly washed intact
human erythrocytes (hematocrit 20% in 5 mM sodium
phosphate (pH 8.0 at 22°C), 150 mM NaCl) were equili-
brated with 50 nM[ 3H]NBMPR in the presence and in the
absence of 20 uM NBTGR, washed free of unbound 3 H-ligand
by one wash in ice-cold medium, and resuspended in
ice-cold medium at a haematocrit of 2%. The cell
suspensions (20 ml) were placed in rectangular uncovered
perspex dishes on ice and exposed to UV light at a
distance of 6.5 cm for 40 s in the presence of 10 mM DTT.
The depth of cell suspension in the dishes was 2 mm. No
detectable haemolysis occured under these conditions and
the cells retained their normal colour. Erythrocytes were
harvested by centrifugation and washed 3 times with 10
volumes of medium containing 10 uM NBTGR and 0.1 mM PMSF.
Haemoglobin-free membranes were then prepared for
SDS-polyacrylamide gel electrophoresis as described in
the previous section except that the 5P8 contained 10 uM
NBTGR and 0.1 mM PMSF. The PMSF was included to minimise
endogenous proteolysis of membrane protein.
2.2.2d SDS-polyacrylamide gel electrophoresis
SDS -polyacrylamide gel electrophoresis was carried
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out in 12% 1 mm thick slab gels by the method of Thompson
and Maddy (1982), using the Laemmli (1970) buffer system.
Samples dissolved in gel sample buffer were not heated
before application to the gel. Radioactivity in the
various regions of the gel was determined by slicing the
gel into 2mm fractions. The 3H-content of these slices
was measured by liquid scintillation counting in toluene
containing 0.4% (w/v) Omniflour and 3% (v/v) Protosol
(New England Nuclear). Vials were allowed to stand at
37°C for 36 hours before counting. The recovery of
applied radioactivity from gels was typically 75-859.
Replicate sample lanes from the same slab gels were




2.3.1 Photolysis under nonequilibrium binding conditions
Young et al., (1983) investigated photolysis of
[ 3H]NBMPR bound to protein-depleted human erythrocyte
membranes. Photolysis was carried out in the absence of
unbound ligand (non-equilibrium binding conditions) to
minimise the possibility of non-specific labelling of
membrane proteins not involved in nucleoside transport.
Protein-depleted membrane were used for the same reason.
Membranes depleted of extrinsic protein retain high
affinity NBMPR-binding activity (Jarvis and Young, 1981).
Fig. 2.1 shows the time course of covalent attachment of
site-bound[ 3 H]NBMPR to normal human erythrocyte
'ghosts'. As was the case with protein-depleted memb-
ranes, UV irradiation of 'ghosts' containing site-bound
[ 3H]NBMPR resulted in substantial covalent incorporation
of radioactivity. Maximum membrane labelling occurred
between 30 and 120 s exposure to light from the mercury
arc lamp, the yield of covalent binding under these
conditions representing ,41% of the site-bound [3 H]NBMPR
prior to photo activation. Site-specific binding of
[ 3 H]NBMPR without photolysis was completely reversible.
Inclusion of a free-radical scavenger (10 mM DTT) during
photolysis decreased the maximum observed co'ralent
incorporation to 27%. Further increases in DTT
concentration (20 and 50 mM) had smaller effects on the
amount of radiolabelling (maximum incorporation, 26 and
Fig. 2.1 Effect of irradiation time on the covalent
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Membranes were labelled with[ 3H]NBMPR (75 nM), washed
free of unbound ligand, and exposed to UV light in the
presence or absence of DTT for graded intervals as.
described in section 2.2.2b. DTT concentrations (mM):
0,( ) 10,(0) 20,( ) and 50,(). Ordinate values
represent covalently bound H expressed as a percentage
of the total membrane-associated 3H-ligand prior to




24%, respectively). Unless noted otherwise, subsequent
photolysis experiments were carried out with a UV
exposure time of 40-45 s in the presence of 50 mM DTT.
Fig.2.2 compares the SDS-polyacrylamide gel electro-
phoresis profiles of Coomassie Blue-stained protein and
co-migrating 3H in human erythrocyte 'ghosts' photo-
labelled with[ 3H]NBMPR as described above. The major
peak of radiolabelling occurred between bands 4.2 and 5
(band 4.5 region of the gel) (Mr = 45,000-66,000), with
smaller amounts of labelling in both higher (Mr 92,000)
and lower molecular weight ranges (Mr = 35,000-45,000).
Of the total H detected in the gel, 62.3% was located in
band 4.5, while 15.8 and 12.2% were located in the minor
high and low molecular weight peaks, respectively. The
minor high and low molecular weight peaks have been shown
to be aggregates and proteolytic degradation products of
the major peak, respectively (Wu et al., 1983 Janmohamed
et al., 1985; see also Chapter 6). Ghosts equilibrated
with [3H]NBMPR in the presence of NBTGR did not exhibit
significant covalent labelling of membrane protein. The
small amounts of 3 H migrating with the tracking dye
presumably represent nonspecific labelling of
phospholipid and/or unbound. 3H-ligand and its degradation.
products.
2.3.2 Intact human erythrocytes
Fig.2.3 shows the results of an experiment in which
intact human erythrocytes were equilibrated with a
Fig.2.2 Distribution of 3H on SDS-polyacrylamide gels of
human erythrocyte 'ghosts' after photoactivation
of site bound [3H]NBMPR.
Membranes were equilibrated with 75 nM[ 3H]NBMPR in the
presence (O) and absence( ) of 20 uM NBTGR, washed free
of unbound ligand, and exposed to UV light for 45s in the
presence of 50 mM DTT. Unreacted [3H]NBMPR was removed by
washing. Samples (0.12 mg of protein) dissolved in gel
buffer were subjected to SDS-polyacrylamide gel electro-
phoresis as described in Section 2.2.2d. The absorbance
scan (633nm) of Coomassie Blue-stained membrane proteins,
3H profiles, and position of molecular weight standards..
are from the same slab gel. a represents the interface
between the stacking and running gels. c is the
corresponding peak on the absorbance scan. The tracking
dye migrated a distance of 10.4cm. 92K, for example,
92,000.
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Fig.2.3 Photoaffinity labelling of intact human erythro-
cyte with [3H]NBMPR.
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Intact human erythrocytes were equilibrated with 50 nM
[3H]NBMPR in the presence (0) and absence (40) of 20 uM
KBTGR, washed free of unbound ligand, and exposed to UV
light for 40 s in the presence of 10 mM DTT. Membranes
were prepared in the presence of 0.1 mM PMSF. Samples
(0.12 mg of protein) were subjected to SDS-polyacrylamide
gel electrophoresis as detailed in Section 2.2.2d (a,




saturating concentration of [3H]NBMPR in the presence and
absence of NBTGR, washed free of unbound ligand, and
exposed to UV light in the presence of 10 mM DTT.
Membranes were prepared from these cells in the presence
of the protease inhibitor PMS F. The radiolabelling
patterns on SDS-polyacrylamide gels were very similar to
those given by the isolated ghosts in Fig.2.2.
2.3.3 Photolysis under equilibrium binding conditions
Because of the high selectivity of labelling
achieved in the above experiments photolysis was
attempted under equilibrium binding conditions. i.e. in
the presence of excess unbound [3H]NBMPR. The labelling
pattern obtained with human erythrocyte 'ghosts' equili-
brated with [3H]NBMPR is shown in Fig.2.4. The majority
of 3H-photoproduct was again located in band 4.5, with
minor high and low molecular weight peaks correspnding to
those observed in the non-equilibrium photolysis experi-
ments. There were slightly increased amounts of 3H
migrating with the dye front, as might be expected from
photolysis 'carried out in the presence of unbound [3H]
ligand. In a control experiment, membranes were equili-
brated with [3H]NBMPR and the resulting suspension
directly solubilized in gel sample buffer and subjected
to SDS-polyacrylamide gel electrophoresis without
exposure to UV light. The only detectable peak of radio-
activity on the gel migrated with the marker dye front
(data not. shown)..
Fig.2.4 Photoaffinity labelling of human erythrocyte
ghosts with[ 3H]NBMPR under equilibrium
binding condition.
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Experimental conditions and procedures were identical to
those described in Fig.2.2 except that unbound [3H ]ligand
was not removed prior to photolysis. Membranes were
equilibrated with[ 3H]NBMPR in the presence (0) and
absence(•) of nonradioactive NBTGR as competing ligand.
The positions of the stacking gel-running gel interface




Fig.2.4 demonstrates that incorporation of 3 H-photo-
product into membrane protein under equilibrium binding
conditions is abolished in the presence of NBTGR as
competing nonradioactive ligand. Subsequent experiments
established that dypyridamole (50 uM), a structurally
unrelated nucleoside transport inhibitor (apparent Ki=
2-20 nM) (Hammond et al., 1981 and Jarvis et al., 1982a),
also reduced[ 3H]NBMPR incorporation into band 4.5 and
the two minor radiolabelled peaks (Fig.2.5). Uridine (5
and 10 mM), a well characterized nucleoside substrate for
the transporter, also inhibited radiolabelling of
membrane protein in a dose-dependent manner (Fig.2.6).
Quantitative estimates of the extent of inhibition of
band 4.5 radiolabelling obtained with these agents is
compared with that for 5 mM adenosine in Table 2.1. As
expected from the relative affinities of uridine and
adenosine for the nucleoside transporter, adenosine was a
more effective inhibitor of 3H incorporation into band
4.5 than uridine. The apparent Ki values (15°C) for
uridine and adenosine inhibition of- reversible high
affinity[ 3H]NBMPR binding activity are 1.2 and 0.1 mM,
respectively (Jarvis et al., 1982a).
2.3.5 Species comparisons
To investigate the relationship between band 4.5
membrane proteins labelled by [3H]NBMPR and those
involved in nucleoside and hexose transport, pig
Fig.2.5 Effect of dipyridamole on [3H]NBMPR photo-
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Ghosts, equilibrated with 75 nM [H]NBMPR in the presence
( 0) and absence of 50 uM dipyridamole(•), were
suplemented with 50 mM DTT and exposed to high intensity
UV light at 4°C for 45 s. SDS-polyacrylamide gel electro¬
phoresis was performed as described in Section 2.2.2d (a,
interface between the stacking and running gels).
Fig.2.6 Effect of uridine on [5H]NBMPR photoaffinity
labelling of human erythrocyte band 4.5.
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Experimental conditions and procedures were the same as
those in the preceding experiment (Fig.2.5) (0(0), 5(a),
and lOmM (A) uridine) (a, interface between the stacking
and running gels).
Table 2.1 Effects of nucleosides and nucleoside transport
inhibitors on covalent [3H]NBMPR incorporation
into band 4.5 proteins of human erythrocyte
membranes.






Data for NBTGR, dipyridamole and uridine are taken from
Figs. 2.4, 2.5 and 2.6, respectively.
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erythrocyte membranes were photoactivated in the presence
of[ 3 HJNBMPR (+NBTGR) under equilibrium binding
conditions. Pig erythrocytes possess approximately 5000
nucleoside transport sites per cell, but lack functional
glucose transporters (Kim and McManus, 1971a,b Jarvis
et al., 1980b Young etal., 1985). The SDS-polyacrylamide
gel 3 H profiles are shown in Fig.2.7. A large NBTGR-
sensitive radioactive peak can be seen in the band 4.5
region of the gel, its apparent molecular weight being
slightly higher than the corresponding human protein(s).
In marked contrast, in an experiment carried out under
indentical conditions, membranes prepared from
nucleoside-impermeable sheep erythrocytes showed no
detectable labelling of band 4.5 membrane protein
(Fig.2.8). These cells lack functional nucleoside
transporters as judged by their inability to transport
nucleosides and by an absence of high affinity NBMPR
binding sites (Jarvis and Young, 1980 Young, 1978).
Unlike pig cells, sheep erythrocytes are able to
transport sufficient glucose for their metabolic needs
(Young, 1978).
Fig.2.7 Photoaffinity labelling of pig erythrocyte
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Experimental conditions and procedures were identical to
those in Fig.2.4. Photolysis in the presence (0)• and
absence(•) of NBTGR, respectively. The positions of the
stacking gel-running gel interface and the tracking dye
are indicated by a and b, respectively.
Fig.2.8 Photoaffinity labelling of nucleoside imperme¬
able sheep erythrocyte membranes with [3H]NBMPR
under equilibrium binding conditions.



















Experimental conditions and procedures were identical to
those described in Fig.2.4. Photolysis in the presence
(D) and absence() of NBTGR, respectively. The positions
of the stacking gel-running gel interface and the
tracking dye are indicated by a and b, respectively.
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2.4 Discussion
High affinity binding of [3H]NBMPR to human erythro-
cyte 'ghosts' represents a specific interaction with
functional elements of the erythrocyte nucleoside
transporter (Young and Jarvis, 1983 Cass et al., 1974
Jarvis and Young, 1980, 1982b). In. a previous study,
Young et al., (1983) reported that exposure of site-bound
3
[ H]NBMPR to UV light resulted in covalent attachment of
the ligand to membranes. Using human erythrocyte
membranes depleted of extrinsic proteins, they
demonstrated a selective incorporation of radioactivity
into band 4.5 polypeptides, proteins with an apparent
molecular weight on SDS-polyacrylamide gels of
45,000-66,000. The photolysis experiments described in
this Chapter represent a detailed investigation of the
covalent photoaffinity labelling of band 4.5 polypeptides
by [3H]NBMPR.
Photolysis experiments were carried out both under
non-equilibrium and equilibrium binding conditions, i.e.
in the absence and in the presence of unbound [3H]NBMPR,
respectively. In the former series• of experiments,
suspensions of erythrocyte 'ghosts' were equilibrated
with a saturating concentration of [3 H]NBMPR at room
temperature, cooled to 4°C, washed free of unbound ligand
and exposed to UV light in the presence of DTT as a free
radical scavenger. In the latter series of experiments.,
membranes were exposed to UV light without the removal of
unbound ligand. In both cases, radioactivity from
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[ 3H]NBMPR was preferentially incorporated into band 4.5
polypeptide(s) of human erythrocyte 'ghosts'. The
presence of relatively high concentrations of unbound
ligand in the equilibrium experiments did not lead to a
significant increase in nonspecific labelling, except in
the lipid region of the gels. Inclusion of nonradioactive
NBTGR during the initial equilibration of[ 3H]NBMPR with
its high affinity binding sites resulted in essentially
complete inhibition of 3 H-labelling of band 4.5.
Typically 60-70% of the 3H-photoproduct bound to 'membrane
protein was located in the band 4.5 region of
SDS-polyacrylamide gels. Proteins of this apparent
molecular weight account for about 4% of the total
membrane protein in human erythrocyte 'ghosts' (Steck,
1974). Photoaffinity labelling of band 4.5 under
equilibrium binding conditions was also inhibited in the
presence of adenosine, uridine, and dipyridamole,
molecules which interact with the nucleoside transporter
and inhibit reversible high affinity[ 3 H]NBMPR binding
activity (see e.g. Jarvis and Young, 1983).
A similar SDS-polyacrylamide gel radioactivity
profile was obtained when[3 H]NBMPR-labelled intact human
erythrocytes were exposed to UV light, demonstrating that
it is possible to specifically photolabel intact cells
with[ 3 H]NBMPR. In this experiment, membranes• were
prepared from the photolabelled erythrocytes' in the
presence of the protease inhibitor, PMSF. The band 4.5
Protein(s) photolabelled by[ 3 H]NBMPR are, therefore,
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unlikely to be proteolytic degradation products of a
larger membrane polypeptide. Similiarly, the band 4.5
glucose transporter is not a proteolytic fragment of a
larger membrane protein (Baldwin and Lienhard, 1980
Mueckler et al., 1985).
These photolysis experiments using intact human
erythrocytes and 'ghosts' provide compelling evidence to
implicate band 4.5 polypeptide(s) in high-affinity
NBMPR-binding activity, particularly when considered in
the context of previous photoaffinity labelling and
isolation studies (Jarvis and Young, 1981 and Young et
al., 1983).
A complementary experimental strategy to test
whether[ 3H]NBMPR does indeed radiolabel the nucleoside
transporter is to exploit species differences in
erythocyte nucleoside transport capacity (Jarvis and
Young, 1980 Young et al., 1980 Jarvis et al., 1982a,b).
As would be predicted, nucleoside-impermeable sheep
erythrocyte membranes failed to incorporate radioactivity
into membrane protein when exposed to UV light in the
presence of[ 3 H]NBMPR under equilibrium-binding
conditions. In contrast, pig erythrocyte membranes gave a
3 H gel electrophoretic profile very similar to that
obtained with human cells, except that the pig band 4.5
peak migrated with a slightly higher apparent molecular
weight than the human protein, a result confirmed in
subsequent detailed comparisons of radiolabelled
membranes from the two species (see Chapter Four).
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Thus, the data presented in this Chapter provide
strong evidence to implicate band 4.5 polypeptides in
nucleoside permeation in both human and pig erythrocytes.
Additional evidence to support this view comes from the
finding that isolated human band 4.5 polypeptides
catalyse NBTGR-sensitive nucleoside transport when
reconstituted into phospholipid vesicles (Tse et al.,
1985). It is, therefore, probable that band 4.5
protein(s) are integral components of the nucleoside
transport mechanism. As detailed in the.. General
Introduction, glucose transport in human erythrocytes
also involves band 4.5 polypeptides. There is, however,
considerable evidence to suggest that cytochalasin
B-sensitive glucose transport and NBTGR-sentive
nucleoside transport are catalysed by separate
polypeptides (see General Introduction and Disscussion).
The present[ 3 H]NBMPR photolysis results with pig
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3.1 Introduction
As detailed in the General Introduction, the human
erythrocyte nucleoside and glucose transporters (about
10,000 and 250,000 copies per cell, respectively)
co-purify during Triton X-100 detergent extraction of
protein- depleted membranes and subsequent DEAE-cellulose
ion- exchange chromatography (Jarvis and Young, 1981
Baldwin et al., 1979). Thus, partially-purified
preparations of the human erythrocyte NBMPR binding
protein contain glucose transporter as .a major
contaminant. As a result, the degree of nucleoside
transporter purification achieved by Jarvis and Young
(1981) was rather modest (13-fold). One wouuld that
greater purification of nucleoside transporter
polypeptides might be achieved using membranes from
erythrocytes lacking glucose transport activity. One such
species is the pig. Pig erythrocytes possess 5000
nucleoside nucleoside transporters per cell (Jarvis
et al., 1980b Young et al., 1985) but are devoid of
glucose transport activity (Kim and McManus, 1971 Young
et al., 1985, 1986 Zeidler et al., 1976). The present
Chapter describes the isolation of the nucleoside
transporter from erythrocytes of this species.
In the experiments described in this Thesis, the
detergent Triton X-100 was replaced by octyl glucoside
(Baldwin et al., 1982). Octyl glucoside has two important-
advantages over Triton X-100. First, it can be completely
removed by dialysis, An contrast to Triton X-100 which
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has a low critical micelle concentration (Yu et al.,
1973) Second, octyl glucoside solutions do not absorb UV
light. Thus, absorbance measurments at 280 nm can be used
to moniter protein levels in column effluents.
The experimental section of this Chapter is divided
into three main parts. The first details some simple
transport experiments confirming the presence of
nucleoside transport activity and the absence of mono-
saccharide transport activity in the pig erythrocytes
used in the present study. The second part describes
experiments designed to optimise the octyl. glucoside
solubilisation of nucleoside transport polypeptides from
pig erythrocyte membranes. The last and major part of
this Chapter describes the isolation and subsequent




3.2.1 Nucleoside and sugar transport studies
3.2.1a Cell preparation
Heparinised whole blood from adult pigs was
collected as described in Chapter 2 (Section 2.2.1b). The
erythrocytes were washed three times with a medium
containing 140mM NaCl, 5 mM KC1, 20 mM Tris-HC1 (pH7.4 at
4oC), 2 mM MgC1, and 0.1 mM EDTA (disodium salt). The
buffy coat was discarded. The haematocrit of cell
suspensions was determined by the microhaematocrit method
(Archer, 1965, 1977).
3.2.1b Nucleoside transport measurements
Uptake of uridine at 25'C was determined., using the
n-dibutylpthalate method of Oliver and Paterson (1971) as
modified by Young and Ellory (1982).. Incubations were
started by rapidly mixing 0.2 ml portions of prewarmed
washed erythrocytes (haematocrit 20%) with 0.2 ml
prewarmed iso-osmotic NaCl medium containing 0.4 mM of
14 C]uridine (53 mCi/mmol). After specified time
intervals (6 s- 480 s), 0.2 ml portions of the cell
suspension, were transferred to an Eppendorf micro-
centrifuge tube (volume 1.5 ml) containing 0.8 ml of
ice-cold stopping solution (iso-osmotic NaCl medium
containing 10 uM NBTGR) layered on top of 0.5 ml of
ice-cold n-dibutylphthalate. Previous studies have
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established that the onset of inhibition by high
concentrations of NBTGR and related compounds (at uM
concentrations) is virtually instantaneous (Cass and
Paterson, 1972; Cabantchik and Ginsberg, 1977; Turnheim
et al., 1978; Harley et al., 1982). The tube was
immediately centrifuged at 10,000g for 15 s using an
Eppendorf 5414 microcentrifuge. The upper layer of
cell-free aqueous medium and the majority of
n-dibutylphthalate was removed by suction, leaving the
cell pellet at the bottom of the tube. After carefully
wipping the inside of the centrifuge tube with. absorbant
tissue, the cells were lysed with 0.5 ml 0.5% (w/v)
Triton X-100 in water and 0.5m1 5% (w/v) trichloro-
acetic acid was added. The precipitate was removed by
centrifugation (2 min, 10,0008). Radioactivity present in
the supernatant was determined by scintillation counting
in 2.5 ml of Packard Picofluor using a Beckman LS7000
scintillation counter with appropriate quench correction.
To estimate the trapped extracellular space of cell
pellets following centrifugation through n-dibutyl-
phthalate, chilled NBTGR-treated cell suspensions were
mixed with ice-cold radioactive nucleoside and 0.2 ml
aliquoats immediately processed as described above.
Transport rates were calculated after subtraction of
these blanks. Unless otherwise stated, values are means
of duplicate or triplicate estimates.
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3.2.1c Monosaccharide transport measurements
incubation procedures were similar to those in the
previous section except that the final extracellular
sugar concentration was 4 mM. At pre-determined time
intervals (15 min to 4 h), incubations were stopped by
removing 0.2 ml of incubation medium into 1 ml ice-cold
iso-osmotic NaC1. medium. The cells were rapidly washed
four times with 1 ml portions of ice-cold medium using an
Eppendorf 5414 microcentrifuge (10 s, 10,0008) (Young and
Ellory,1982). Cell pellets were then processed for radio-
activity determination as described in Section 3.2.1b.
3.2.2 Assay of reversible NBMPR-binding
3.2.2a Washing procedure
Erythrocyte ghosts and protein-depleted membranes
(0.1 ml, 1 mg protein/ml in 5P8) were incubated with an
equal volume of [3H]NBMPR (0.5-150 nM) for 30 min at room
temperature in the presence and absence of 10 uM non-
radioactive NBTGR. Incubations were terminated by
centrifugation at 10,0002 for 15 min at 4°C in an
Eppendorf 5414 microcentrifuge. Supernatants were
retained for radioactivity determinations and the
membrane pellets were washed four times with 1 m1
aliquots of ice-cold buffer. After the final wash,
membrane pellets were dissolved in 5% (w/v) Triton X-100
(0.5 ml) and 0.4 ml removed for radioactivity
determination with appropriate quench correction.
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3.2.2b Equilibrium dialysis method
The equilibrium dialysis apparatus used had 0.25 ml
chambers and employed 12,000-14,000 molecular-weight
cut-off membranes (Hoefer Scientific Instruments, San
Francisco, CA, U.S.A.). Dialysed membrane extracts (0.2
ml) were added to one side of the dialysis membrane, and
0.2 ml portions of[ 3H]NBMPR (0.5-150 nM) in identical
medium to the other, in the absence or in the presence of
10 uM NBTGR (to correct for non-specific binding).
Samples with high binding activity were diluted up to
5-fold with the appropriate buffer before assay. Each
dialysis well also contained a 2 mm glass bead to assist
mixing. The apparatus was rotated gently for 20 h at room
temperature. Aliquots (0.1 ml) were then removed from
each chamber for determination of radioactivity.
3.2.2c Centrifugal gel filtration method
In some experiments, a centrifugal gel filtration
method originally devised for vesicle transport assays
(see Section 3.2.5b) was used as an alternative to
equilibrium dialysis. Sephadex G-50 beads were swollen
Dvernight in 10 mM Tris pH 7.4 at 4°C. After de-gasing
for 1-2 h, the beads were packed under gravity to the 1
ml mark of 1 ml disposable syringes (0.5 x 16 mm). The
packed columns were allowed to drain dry and cooled to
4°C in a cold room, all subsequent procedures also being
preformed at 4°C unless otherwise stated.
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Dialysed membrane extracts (37.5 ul) were incubated
with an equal volumes of[ 3 H]NBMPR (0.5-150 nM) for 20
min at room temperature in the absence and in the
presence of 10 uM NBTGR. Incubation mixtures were then
cooled to 4°C. Just before use, the mini-columns were
centrifuged in an IEC clinical table-top centrifuge
(5002) for 2 min. Reaction mixture (75 ul) was then added
and allowed to run into the column. After 15 s, 20 ul of
buffer was added to wash-in the mixture, and the mini-
columns recentrifuged for a further 2 min. Liquid eluting
from the column was collected directly into mini-
scintillation vials and assayed for radioactivity.
Control experiments confirmed that equilibrium dialysis
and the Sephadex mini-column method gave equivalent
estimates of NBMPR-binding to pig erythrocyte membrane
extracts.
3.2.3 Pilot isolation studies
3.2.3a Membrane preparation
These and subsequent experiments were carried out at
4°C unless. otherwise stated. Haemoglobin-free 'ghosts'
were prepared from freshly collected heparinized human
and pig blood as described in Chapter 2,. Section 2.2.2a,
except that the initial haemolysis medium contained 0.1
mM PMSF to minimise endogenous proteolysis. Control
experiments established that this concentration. of P M S F
did not inhibit nucleoside transporter function.
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Protein-depleted membranes were prepared by a single
extraction step using 0.1 mM EDTA, pH 11.2 (Jarvis and
Young, 1981). Membranes (1 volume) were exposed to 7
volumes of ice-cold EDTA solution for 15 min. The
erythrocyte membranes were sedimented by centrifugation
(35,0002 for 25 min) and washed twice with 5 or 50 mM
Tris-HC1 (pH 7.4 at 4°C). Membranes were resuspended by
homogenisation after each wash and stored at -70°C.
Human and pig protein-depleted erythrocyte membranes
(4 and 3 mg of protein/ml, respectively) in 50mM Tris-HC1
(pH 7.4 at 4°C), 2 mM DTT were solubilised by the
addition of an equal volume of 92 mM octyl glucoside in
Tris buffer also containing 2 mM DTT. The preparation was
stirred for 20 min, then centrifuged at 130,0008 for lh
using a Beckman L5-50 ultracentrifuge. Supernatants
(referred to as crude membrane extract) were retained.
3.2.3b Column chromatography
Ion-exchange chromatography of octyl glucoside
membrane. extracts was carried out as described by Baldwin
et al., (1982). The crude extract (2 vol.) was applied to
a column containing 1 vol. of DEAE-cellulose equilibrated
with 34 mM octyl glucoside in 50 mM Tris-HC1 (pH 7.4 at
4°C), 2 mM DTT and the column was then eluted with 3 vol.
of the same buffer at a flow rate of 2.5 column volumes
per hour. Protein bound to the column was eluted with the
same buffer supplemented with 1M-NaCl. Protein-containing
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fractions were detected by their absorbance at 280nm and
pooled. Detergent was removed by dialysis against four
changes, each of 2 litres of 50mM sodium phosphate, 100mM
NaCl, 1mM EDTA, pH7.4, over a period of 48 hours.
Reversible NBMPR-binding activity and protein content
were assayed as described in Sections 3.2.2c and 3.2.5a,
respectively.
3.2.4 Isolation studies
In these experiments[ 3 H]NBMPR photoaffinity
labelled membrane material was used in order to identify
column fractions containing NBMPR-binding protein(s) and
to monitor the degree of purification achieved.
3.2.4a Membrane preparation
Protein-depleted membranes prepared as „described
previously (Section 3.2.3a) were photolabelled with
[ 3H]NBMPR using the non-equilibrium labelling procedure
described in Chapter 2, Section 2.2.2b. After UV
exposure, samples were diluted 20-fold with 5 or 50 mM
Tris-HC1 and allowered to stand at room temperature for
10 min before recovery of the radiolabelled membranes by
centrifugation. This washing procedure was repeated two
more times to remove residual unreacted- ligand. 10 uM
NBTGR was present in the first wash.
In large scale preparative experiments for
reversible NBMPR-binding and reconstitution studies, only
5% of the protein-depleted membranes were photolabelled
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with[ 3 H]NBMPR and no NBTGR was present in the washing
steps.
3.2.4b Column chromatography
Photolabelled protein-depleted membranes were
solubilised in 50 mM Tris- H C1 (pH 7.4 at 4°C), 2 mM DTT,
46 mM octyl glucoside as described in Section 3.2.3a.
Fractions collected from the ion-exchange column (see
Section 3.2.3b) were assayed both for radioactivity and
protein.
In later experiments, the DEAE-cellulose columns
were eluted with linear salt gradients. Here membranes
were solubilised in 46 mM octyl glucoside, 2 mM DTT in 5
mM Tris-HC1. The DEAE-cellulose ion-exchange column was
equilibrated with 34 mM octyl glucoside, 2 mM DTT in 5 mM
Tris- H C1 and eluted with 800 ml of a linear salt gradient
(0-0.2 M NaC1 in the same buffer). Column fractions
containing nucleoside protein (0.8-0.11 M NaCl) were
pooled and dialysed free of detergent as described- in
Section 3.2.3b. Residual proteins remaining bound to the




Protein fractions were reconstituted into phospho
lipid vesicles using the method described previously by
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Kasahara and Hinkle (1977) as modified by Tse et al.
(1985). Acetone washed soybean phospholipids (Kagawa and
Racker, 1971) (20-40 pmol in 0.5m1 of 50 mM Tris-HC1)
were sonicated to clarity (20 min at 20- 30°C) in a
bath-type sonicator (G112-SP1, Laboratory Supply Company
Inc., Hicksville, NY) containing 0.02% (w/v) Triton X-100
in distilled water (Kasahara and Hinkle, 1977). Samples
(0.018-0.15 mg of protein) were added to the sonicated
vesicles (4-8 umol) in a final volume of 0.4 ml. The
phospholipid: protein ratio (umol/mg) was kept in the
range 50-240: 1. The mixture was rapidly frozen in dry
ice/ethanol, slowly thawed at room temperature, and then
sonicated briefly (5 s). These preparations were then'
used for uridine and glucose uptake studies.
3.2.5b Transport assays
Uptake of[ 14 C]uridine (50 uM) by liposomes and
reconstituted vesicles was measured at 20°C by a centri-
fugal gel filtration method (Baldwin et al., 1981
Zeidler et al., 1976 Fry et al., 1978) as described by
Tse etal., (1985). Uptake of D- and L-[ 14C]glucose (0.2
mM) was determined by an identical procedure except that




3.2.6a SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis and detection
of radioactivity in gels were carried out as described in
Chapter 2, Section 2.2.2d. Protein was visualised by
staining with Coomassie Blue.
3.2.6b Protein determination
Protein was measured by the method of Peterson
(1977). Briefly, samples were first made up to 0.5 ml
with water, mixed with 0.05 ml of sodium deoxycholate
(0.15%, w/v) and then 0.05 ml T CA (72%, w/v) was added.
Protein was sedimented by centrifugation for 5 min at
10,0002 using an Eppendorf microcentrifuge. The super-
natants were discarded and the samples were made back to
the original volume (0.5 ml) with distilled water. The
pellets were solubilised by the addition of 0.5 ml of
reagent containing 2.5% (w/v) Na Z C03, 0.025% (w/V) CuSOq,.
5H20, 0.05% (w/v) potassium sodium tartrate, 2.5% (w/v)
S DS and 0.2 N NaOH. Finally, 0.25 ml of a 1: 5 dilution
of Folin and Ciocalteau's phenol reagent was added. The
absorbance at 750 nm was measured 30 min later. Bovine
serum albumin was used as standard.
3.2.6c Lipid determination
Phospholipid was assayed by the diphenyihexatriene--





As expected from previous studies of uridine
transport in pig red blood cells (Jarvis et al., 1980b),
uptake of 0.2mM uridine at 25°C was rapid, with cells
reaching steady state uridine concentration of 0.14
mmol/1 cells within 2 min (Fig. 3.1). This corresponds to
an equilibrium intracellular concentration of about 0.2
mM, assuming pig red blood cells contain 70% (v/v) water.
Subsequent experiments used a 5 s incubation period
to measure initial rates of zero-trans uridine uptake. As
shown in Fig. 3.2, transport of uridine was virtually
completely inhibited by 0.25 um of NBMPR. On the other
hand, concentrations of cytochalasin B up to 5 uM did not
affect uridine transport.
Fig. 3.3 shows time courses of D- and L-glucose
uptake (4 mM extracellular concentration) by pig red
blood cells. Influx was slower that that of uridine and
not selective for the isomers (0.012 and 0.015 mmol/l
cells per h for L- and D-glucose respectively). Uptake
was also not inhibited by 10 uM cytochalasin B (data not
shown) and therefore probably reflects non-specific
diffusion of radio-ligand across cell membrane.
The ability of pig red blood cells to transport 3-0-
methyl-glucose was also investigated. In contrast to D/L-
glucose, uptake was relatively rapid (initial rate= 0.42'
mmol/1 cells per h). This uptake was not inhibited by
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The initial extracellular uridine concentration was 0.2
mM and the experiment was carried out at 20 C.
Incubations were terminated by the oilinhibitor method












Fig.3.2 Effects of NBTGR and cytochalasin-B on uridine
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Cells were preincubated with different concentrations
(0-0.5 uM) of NBMPR(•) or cytochalasin-B (O) for 20 min
prior to addition of[ l4C]uridine (0.2 mM) at 20°C;
Incubations (6 s) were terminated by the oilinhibitor
method described in Section 3.2.1b.
Fig. 3.3 Time courses of 3-0-methyl glucose, D-glucose
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Uptake of D-glucose( O), L-glucose(), 3-0-methyl
glucose (0) and 3-0-methyl glucose in the presence of
cytochalasin B(•) (30 uM) were measured at 37°C (4mM
extracelular concentration).
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cytochalasin B and again presumably represents diffusion
of the permeant through the lipid bilayer, this sugar
have a higher lipid solubility than D- and L-glucose. The
absence of a functional glucose transporter from pig
erythrocyte membranes was evident in subsequent
reconstitution experiments (see Section 3.3.6).
3.3.2 Octyl glucoside solubi l-sation
Because Triton X-100 reversibly inhibits NBMPR
binding activity (Jarvis and Young, 1981), the effect of
octyl glucoside on NBMPR binding to erythrocyte --membranes
was evaluated. Figs. 3.4 and 3.5 show results from
equilibrium dialysis experiments in which NBMPR binding
to human and pig erythrocyte membranes was measured in
the presence of increasing concentrations of detergent
(0.34-50 mM). As was found previously for Triton X-100,
octyl glucoside inhibited NBMPR binding. The data also
demonstrate a species difference with respect to
sensitivity to octyl glucoside inhibition. Thus, octyl
glucoside was a more effective inhibitor of NBMPR binding
to pig membranes than to human. Complete inhibition of
pig membrane NBMPR binding activity was achieved by the
addition of 17 mM octyl glucoside, compared with only 40-
inhibition in human membranes at this detergent
concentration.
As shown in Figs. 3.6 and 3.7, -there were, also
species differences with respect to the ability- of octyl
Fig.3.4 Effect of octyl glucoside on the binding of









Human erythrocyte membranes (2mg/mi) were treated with
various concentrations of octyl glucoside in lmM-DTT and
analysed by equilibrium dialysis for NBMPR-binding
activity in the presence of detergent with (0) or without
(•) NBTGR (10 uM). The concentration of NBMPR was lnM
(average of both chambers). Binding activity is expressed
as a distribution ratio (radioactivity present in chamber
containing erythrocyte membranes: radioactivity present
in opposite chamber).
Distributionratio
Fig.3.5 Effect of octyl glucoside on the binding of






Pig erythrocyte membranes were treated. with. octy:
glucoside and assayed for NBMPR-binding activity wa:
assayed in the absence(•) or in the presence of lout
NBTGR (0) as described in Fig.3.4.
Distrbutionratio
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glucoside to solubilise protein-depleted membranes. For
human membranes (Fig. 3.6), increasing concentrations of
octyl glucoside (6.8-50 mM) resulted in progressive
solubilisation of membrane protein, reaching a maximum of
46% at 46 mM octyl glucoside. In contrast, 34 mM octyl
glucoside caused a sudden solubilisation of pig membrane
protein (Fig. 3.7). Maximum solubilisation again occurred
at 46 mM octyl glucoside, but was more complete (88%)
than with human membranes. NBMPR binding assays
established that extraction of pig erythrocyte membranes
with 34 mM octyl glucoside and subsequent removal of
detergent by dialysis resulted in essentially complete
solubilisation and quantitative recovery of NBMPR binding
activity (Fig. 3.7). Octyl glucoside (46 mM) was required
to achieve the same result with human membranes (Fig.
3.6).
The octyl glucoside concentration used in all
subsequent experiments was 46 mM. Human and pig
erythrocyte protein-depleted membranes were solubilised
at concentrations of 2 and 1.5 mg protein/ml, respect-
tively. This ensured that the protein contents of the
solubilised, extracts from the two species were both in
the region of 1 mg protein/mi.
3.3.3 Pilot studies
The standard procedure in this laboratory for
isolation of human erythrocyte band 4.5 polypeptides'
involves solubilisation of protein-depleted membranes in
Fig.3.6 Solubilisation of human erythrocyte membranes





























Protein-depleted membranes at a concentration of 4mgml
were treated with various concentrations of octyl
glucoside in 1 mM DTT at 4°C for 30 min. The mixtures
were centrifuged at 130,000g for lh and the supernatant
dialysed to remove detergent before assay of NBMPR-
binding activity(•) and protein content().
Fig.3.7 Solubilisation of pig erythrocyte membranes and
























Protein-depleted membranes (4mgml) were treated as in
Fig.3.6. NBMPR-binding activity() and protein content
































































Table 3.1. Solubilisation and DEAE-cellulose chromatography of NBMPR-binding activity from human and
pig erythrocyte membranes. 'Ghosts' were depleted of extrinsic proteins, solubilised with octyl
glucoside and subjected to DEAE-cellulose ion-exchange column chromatography in a medium containing
34 mM octyl glucoside, 50 mM Tris-HCl (pH7.4 at 4°C) and 2 mM DTT• (see Section 3.2.3). Samples of the
octyl glucoside 130,000 supernatant (crude octyl glucoside extract) and pooled void-volumn and 1M
NaCl fractions from the column were dialysed free of detergent and assayed for protein and high-
affinity NBMPR-binding activity (at a saturating concentration of ligand). Values are means(+_ SEM)
of three separate experiments for each species.
46 mM octyl glucoside, 2 mM DTT, 50 mM Tris-HCl (pH 7.4
at 4°C) followed by DEAE-cellulose ion-exchange
chromatography, with the result that band 4.5
polypeptides remain in the column void-volume (Baldwin
etal., 1982). As shown in Table 3.1a, this method
resulted in a 12.7-fold purification of reversible
high-affinity NBMPR-binding activity compared with the
starting erythrocyte 'ghosts'. In three separate
experiments the mean NBMPR-binding capacity of the pooled
void-volume extract was 456 pmolmg protein. The recovery
of NBMPR-binding activity was 23%. These values compare
favourably with the 12.9-fold purification (31% recovery)
obtained previously using Triton X-100 as detergent
(Jarvis and Young, 1981).
In marked contrast, only a small percentage of the
pig erythrocyte NBMPR-binding activity remained in the
column void-volume under these conditions (Table 3.1b).
In consequence, the average specific activity of NBMPR-
binding following column chromatography was only 95
pmolmg protein, a purification of 4-fold (recovery 5%).
Most of the NBMPR binding activity (33%) was recovered
along with other integral membrane proteins (principally, • »
the band 3 anion exchange transporter) in the 1 M NaCl
extract (specific activity 42 pmolmg protein). The 1 M
NaCl extract from human erythrocyte membranes also
contained band 3, but minimal NBMPR-binding activity (see
also Jarvis and Young, 1981).
The difference in the elution profiles for the human
and pig erythrocyte NBMPR-binding proteins was confirmed
in a series of experiments in which protein-depleted
membranes from the two species were covalently labelled
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with[ H]NBMPR prior to octyl glucoside solubilisation
and ion-exchange chromatography. As shown in Fig. 3.8,
most of the (92%) associated with the human
erythrocyte membrane extract was recovered in the column
void-volume (fractions 4-12). Chromatography of
solubilised membranes which had been photoaffinity
labelled with [H]NBMPR in the presence of excess NBTGR
(20 uM) confirmed that most of the appearing in the
column void-volume was specifically associated with the
nucleoside transporter (see also Fig. 3.8). As expected
from the results presented in Table IB, the radiolabelled
pig erythrocyte NBMPR-binding protein was adsorbed by the
column and eluted in the 1M NaCl fractions (Fig. 3.9).
These experiments establish the validity of using
radiolabelled-NBMPR as a covalent probe of the solubil¬
ised NBMPR-binding protein.
3.3.4 Isolation studies (gradient-elution)
Subsequent fractionation experiments employed
gradient elution of the ion-exchange column to separate
the pig nucleoside transporter from band 3 and other
integral membrane proteins, covalent labelling with
[ H]NBMPR being used to monitor the elution position of
the solubilised NBMPR-binding protein and to quantify the
Fig.3.8 D E AE-cellulose chromatography of the NBMPR-
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Protein-depleted membranes were photolabelled with
[ 3H]NBMPR in the presence (0) and absence (Q) of 20 uM
NBGTR, solubilised in octyl glucoside and subjected to
DEAE-cellulose ion-exchange chromatography in a medium
containing 34 mM octyl glucoside, 50 mM Tris-HCl (pH 7.4
at 4cC) and 2 mM DTT (see Section 3.2.4b for details).
Aliquots (0.1 ml) were removed from each fraction for
radioactivity determination. Protein (A) was monitered at
280nm.
Fig.3.9 DEAE-cellulose chromatography of the NBMPR-
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Protein-depleted membranes were photolabelled with
[ 3H]NBMPR in the presence (0) and absence() of 20 uM
NBTGR, solubilised in octyl glucoside and subjected to
DEAE-cellulose ion-exchange chromatography in a medium
containing 34 mM octyl glucoside, 50 mM Tris-HCl (pH 7.4
at 4°C) and 2 mM DTT (see Section 3.2.4b for details).
Aliquots (0.1 ml) were removed from each fraction for
radioactivity determination. Protein (A) was monitered at
280nm.
Fig.3.10 Gradient-elution DEAE-cellulose chromatography of
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Protein-depleted membranes were photolabelled with[ 3H]-
NBMPR, solubilised in octyl glucoside and subjected to
gradient-elution ion-exchange chromatography on DEAE-
cellulose (0-0.2 M NaCl; 34 mM octyl glucoside, 5 mM
Tris-HCl (pH 7.4 at 4°C), 2 mM DTT) as detailed in. Section
3.2.4b. Aliquots (0.1 ml) were removed from each fraction
for radioactivity determination(). Protein (O) was
monitored at 280nm.
degree of purification achieved. Results from a
representative separation are shown in Fig. 3.10. In
agreement with the earlier experiments, only small
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amounts of H and protein were detected in the column
void-volume fractions (4-12). Subsequent gradient elution
of the column (5 mM Tris-HCl; 0-0.2 M NaCl) released the
majority of adsorbed radioactivity in a single peak (0.09
M NaCl) in fractions exhibiting a 280nm absorbance of
0.05. The remaining H and most of the protein
(including band 3) eluted at higher ionic strength. Total
3
recovery of H from the ion-exchange column was 85%,
three-quarters of which chromatographed in the 0.09 M
NaCl peak.
The radioactivity present in samples from the column
void-volume, the 0.09 M NaCl peak and the 1 M NaCl peak
were analysed by SDS-polyacrylamide gel electrophoresis.
As shown in Fig. 3.11, there was no radiolabelled protein
detectable in the column void-volume, the small amount of
3
H present in these fractions migrating in the lipid
region of the gel. In contrast, 90% of the radioactivity
present in the 0.09 M NaCl fraction migrated as a large
band 4.5 peak with an apparent Mr (average) of 64,000,
the expected apparent molecular weight of the pig
erythrocyte nucleoside transporter (Chapter 2, Section
2.3.5;, Chapter 4, Section 4.3.1). The minor high
molecular weight peak (apparent Mr (average) 92,000) and
low molecular weight peak (apparent Mr (average) 45,000)
correspond to aggregates of the transporter and
Fig.3.11 S DS-poly acrylamide gel electrophoresis of 3H-
containing fractions isolated from radiolabelled
pig erythrocyte membranes by gradient-elution
DEAE-cellulose chromatography.
Aliquots (0.1ml) was removed from fraction nos. 7
(void-volume, A), 46 (gradient peak,•) and 85 (1M NaCl
peak, 0) of the experiment shown in Fig. 3.10, mixed with
an equal volume of gel sample buffer and subjected to
SDS-polyacrylamide gel electrophoresis in a 12% (wv)
slab gel. Radioactivity in the various regions of the gel
were determined by slicing gel lanes into 2 mm fractions
and counting by liquid scintillation spectrometry (see
Section 2.2.2d). H-Profiles for the three samples and
the positions of molecular weight standards are from the
same slab gel. The positions of the stacking gel-running













proteolytic degradation products, respectively (Wu et
al., 1983 Janmohamed et al., 1985). A small amount of
[3 H]NBMPR-binding protein was detected in the 1 M NaCl
fraction.
To assess purification of the NBMPR-binding protein,
radioactive 0.09 M NaCl fractions were pooled, dialysed
free of detergent and assayed for both total protein
(Peterson, 1977) and protein-associated radioactivity as
determined by SDS-polyacrylamide gel electrophoresis (see
above). In a representative experiment, the specific
activity of protein-bound 3H was 2982 cpm/ug protein for
the 0.09 M NaCl preparation compared with 50.4 cpm/ug
protein for protein-depleted membranes. Thus, membrane
solubilisation and subsequent ion-exchange chromatography
resulted in a 59-fold purification of radiolabelled
NBMPR-binding protein. The average purification achieved
in 3 separate experiments (mean+ S EM) was 60+ 3-fold.
Analysis of the protein composition of the purified
extract by Coomassie Blue staining of SDS-polyacrylamide
gels (Fig. 3.12) revealed the presence of two protein
bands, one with an apparent Mr (average) of 64,000
corresponding to the mobility of the radiolabelled
NBMPR-binding protein, the other with a lower apparent Mr
(average) of 43,000 (see also Chapter 4, Section 4.3.1).
Absorbance scans from 3 separate isolation experiments
gave essentially identical results, the higher molecular
weight species contributing. 40+ 2% of the protein
present in the preparation.
Fig.3.12 SDS-polyacrylamide gel electrophoresis of pig
erythrocyte 'ghosts' and partially-purified band
4.5 polypeptides.
The NBMPR-binding component from pig erythrocyte
membranes was isolated by gradient-elution DEAE-cellulose
chromatography as described in the legend to Table 3.2
and concentrated by ultracentrifugation (130, 0002, 45
min). Samples of the starting erythrocyte ghost
preparation, (75 ug protein, sample A) and the purified
extract (30 ug protein, sample B) were analysed on a 12%
SDS-polyacrylamide slab gel, stained with- Coomassie Blue
and. scanned at 633 nm using a LKB laser densitometer. The
shaded area corresponds to the 3H-profile of purified
extract (30 ug) radiolabelled with[ 3H]NBMPR.- The-
positions of the stacking gel- running gel interface and



















































This partially-purified band 4.5 preparation had a
relatively low lipid content, most (75%) of the
solubilised phospholipids eluting in the column
void-volume. The percentage of solubilised phospholipids
recovered in the pooled 0.09 M NaCi fractions was
typically 10% of that present in the starting material.
The measured phospholipid: protein ratio of one
preparation was 23.2 umol/mg compared with 1.64 umol/mg
for the crude octyl glucoside membrane extract.
3.3.5 Reversible NBMPR-bindin
Ligand binding assays at each stage of the
gradient-elution isolation procedure are. summarised in
Table 3.2. Mean specific activities of NBMPR-binding to
the partially-purified band 4.5 preparation and the
starting erythrocyte 'ghosts' were 1450 and 23 pmol/mg
protein, respectively, representing an overall increase
in specific activity of 63-fold. This contrasts with a
13-fold increase in specific activity for the human
erythrocyte preparation (Table 3.1a).
Membrane solubilisation and column chromatography
alone increased the specific activity of reversible
NBMPR-binding by 29-fold. This compares with 60-fold for
covalent NBMPR-radiolabelling (see previous section). The
discrepancy between these two figures can be accounted
for by the 50% loss of reversible ligand-binding activity
during the column chromatography stage of the -isolation
procedure (Table 3.2), reversible NBMPR-binding activity
underestimating the. extent of purification achieved. A
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corresponding loss of human erythrocyte NBMPR-binding
activity is apparent in Table 3.1a. It should also be
noted that the data presented in Table 3.2 confirm the
low NBMPR-binding activities of the pig erythrocyte void-
volume solution and 1 M NaCl fractions (see also Fig.
3.10 and 3.11).
Reversible NBMPR-binding to the partially- purified
band 4.5 preparation is analysed more fully in Fig. 3.13
which presents representative data for the concentration
dependence of binding, measured both in the presence and
in the absence of 20 uM nonradioactive NBTGR. NBTGR-
sensitive binding was saturable with an apparent
dissociation constant (Kd) of 7.2 nM. This value was
5.1-fold higher than the apparent Kd (1.4 nM) for
high-affinity NBMPR binding to membrane 'ghosts' and
crude octyl glucoside extract from the same blood sample.
It seemed likely that this shift in Kd was related to the
altered lipid environment of the NBMPR-binding protein
(see previous section). Supplementation of the crude
octyl glucoside extract with 0.11 M NaC1 to permit
elution of the NBMPR- binding protein in the ion-exchange
column void-volume along with the majority of solubilised
membrane lipids reduced the measured apparent Kd to 3.0
nM. This compares. with an apparent Kd value of 2.4 nM for
the human erythrocyte band 4.5 preparation of Jarvis and
Young (1981). The NBMPR-binding activity of the igolated
pig preparation had a half-life of 40 days when stored at
-70°C.
Fig.3.13 Concentration dependence of NBMPR-binding to































The amounts of[ H]NBMPR bound to the partially-purified
band 4.5 preparation (see legend to Fig. 3.12) in the
absence(•) and presence (0) of 20 uM NBGTR was
determined by equilibrium dialysis and is plotted against
the equilibrium concentrations of free NBMPR. The inset
shows a Scatchard plot of the data (corrected fpr the
NBTGR- insensitive component). Maxium binding (1690
pmolmg protein) and apparent Kd (7.2 nM) were determined
by linear regression analysis.
Specific NBMPR-NBMPR-bindingTo to l NBMPETotal protein
binding activityactivity recoveredbound (pmol)(mg)
( % ) (pmol/mg protein)
23+ 1'Ghosts' 100210+ 10.0 4830+ 321
864150+ 105 50+384+ 2.9Protein-depleted membranes
80 61+ 33864+ 9764+ 4.0Octyl glucoside supernatant.
DEAE-cellulose fractions
9+ 10.418+ 22.1+ 0.2(a) Void-volume
29 1450+ 590.95+ 0.04 1385+ 94(b)-Gradient
2+ 11.363+740+ 5.6(c) 1 M NaC1
Table 3.2. Purification of the NBMPR-binding component from pig erythrocyte membranes. 'Ghosts
were depleted of extrinsic proteins, solubilised with octyl glucoside and subjected to gradient-
elution ion-exchange chromatography on DEAE-cellulose (0-0.2 M NaCl 34 mM octyl glucoside, 5mM Tris-
HC1 .(pH 7.4 at 4°C), 2 mM DTT) as described in the Methods section. Samples of the octyl glucoside
130,0008 supernatant (crude octyl glucoside extract) and pooled void-volume, gradient and 1M NaCl
fractions from the column were dialysed free..of detergent and assayed for protein and high-affinity
NBMPR-binding, activity (at a saturating concentration of ligand). Gradient fractions (0.08-0.11 M
NaCl) containing the NBMPR-binding protein were identified by covalently labelling 5% of the protein-




The purification experiments presented in preceding
sections established conditions for the isolation of a
membrane protein fraction from pig erythrocytes which is
substantially enriched with respect to NBMPR-binding
activity. Subsequent experiments were undertaken to
investigate whether this partially-purified band 4.5
preparation was also capable of nucleoside transport when
reconstituted into phospholipid vesicles. Conditions for
reconstitution and assays of uridine uptake were based on
reconstitution studies of the human erythrocyte
nucleoside transporter (Tse, et al., 1985).
Data for representative reconstitution experiments
for the crude octyl glucoside membrane extract and the
isolated band 4.5 preparation are given in Figs. 3.14 and
3.15. When reconstituted, both preparations imparted
carrier- mediated (NBTGR- sensitive) uridine uptake
activity (50 uM, 25°C), the latter exhibiting a 30-fold
higher initial rate of transport (5 s flux) per mg
protein than the former (Table 3.3). Within experimental
error, ion-exchange chromatography resulted in parallel
increases in the specific activities of both uridine
transport and reversible NBMPR- binding. From the data
presented in Table 3.3, it can be calculated that the
purified pig preparation catalysed the transport of 9
molecules of uridine/NBMPR-binding site in 5 s (50 uM
permeant, 25°C). This value compares favourably with a
rate of 2.5 molecules/site in 5 s for human erythrocyte
Uridine transportNBMPR-binding
activityactivity
(pmol/mg protein) (pmol/mg protein in 5s)
0.35+ 0.0260+ 3rude octyl glucoside
extract
10.80+ 0.54Partially-purified 1200+ 90
band 4.5 proteins
31Ratio 20
Table 3.3. High-affinity NBMPR-binding and uridine transport
activities of partially-purified band 4.5 polypeptides and
crude octyl glucoside extract from pig erythrocyte membranes.
Membranes were depleted of extrinsic proteins, solubilised
with octyl glucoside and subjected to gradient- elution
DEAE-cellulose ion-exchange column chromatography as described
in the Methods section. Samples of the octyl glucoside
130,000.q supernatant (crude octyl glucoside extract) and
partially-purified band 4.5 polypeptides were dialysed free of
detergent and assayed for high-affinity NBMPR-binding activity
at a saturating concentration. of ligand. Samples of the two
preparations were also reconstituted into phospholipid
vesicles and assayed for NBTGR-sensitive uridine transport
activity (50 uM,[ C]uridine+ 20 uM NBTGR, 25°C) as detailed
in the text. Values are means(+ S EM) of triplicate estimates
from a single experiment.
Fig.3.14 Time course of uridine uptake into vesicles
reconstituted with crude octyl glucoside extract









The 130,0002 supernatant from octyl glucoside-solubilised
protein-depleted membranes (crude octyl glucoside
extract) was dialysed free of detergent and reconstituted
into phospholipid vesicles as described in Section 3.2.5.
Uptake of[14 C]uridine (50uM) in the absence (0) and in
the presence (0) of 20uM NBTGR was measured at 25°C. The
inset. shows the time course of NBTGR-sensitive uridine
transport ( is the difference between uridine. uptake in
the absence and in the presence of NBTGR). Values are
means of triplicate determinations.
Uridineuptake( rnoles/mgprotein)
Fig.3.15 Time course of uridine uptake into vesicles
reconstituted with partially-purified band 4.5
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Partially-purified band 4.5 polypeptides (see legend to
Fig. 3.13) were reconstituted into phospholipid vesicles
and assayed for uridine uptake (50 uM, 25°C) in the
presence (0) and absence(•) of 20 uM NBTGR. The inset
shows the time course of NBTGR-sensitive uridine
transport (A is the difference between uridine uptake in
the absence and in the presence of NBTGR). Values are
means of triplicate determinations.
Fig.3.16 Time courses of D- and L-glucose uptake into
vesicles reconstituted with crude octyl
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The 130,000c[ supernatant from octyl glucoside-solubilised
protein-depleted human (A) and pig erythrocyte membranes
(B) were dialysed free of detergent and reconstituted
into phospholipid vesicles under identical conditions.»
Uptake of 50 uM D-[ C]glucose() and L-[ |lfC]glucose (O)
were measured at 25°C as described in Section 3.2.5.





(pmolmg protein) (pmolmg protein in 5s
Crude octyl glucoside
extract
60+ 3 0.35+ 0.02
Partially-purified
band 4.5 proteins
1200+ 90 10.80+ 0.54
Ratio 20 31
Table 3.3. High-affinity NBMPR-binding and uridine transport
activities of partially-purified band 4.5 polypeptides and
crude octyl glucoside extract from pig erythrocyte membranes.
Membranes were depleted of extrinsic proteins, solubilised
with octyl glucoside and subjected to gradient- elution
bEAE-cellulose ion-exchange column chromatography as described
the Methods section. Samples of the octyl glucoside
I30,000g supernatant (crude octyl glucoside extract) and
Partially-purified band 4.5 polypeptides were dialysed free of
detergent and assayed for high-affinity NBMPR-binding activity
at a saturating concentration of ligand. Samples of the two
Preparations were also reconstituted into phospholipid
Vesicles and assayed for NBTGR-sensitive uridine transport
a°tivi ty (50 uM,[ 14C'Juridine+ 20 uM NBTGR, 25°C) as detailed
the text. Values are means(+_ SEM) of triplicate estimates
Trom a single experiment.
Uridine uptake (pmol/lOs -assays)
-NBTGR +NBTGR
Crude octyl glucoside extract
2.79+ 0.16 4.32+ 0.377.11+ 0.33Reconstituted vesicles
3.08+ 0.64 02.94+ 0.22Lipid only
0.12+ 0.1000.1.2+ 0.10Protein only
Partially-purified band 4.5
16.20+ 1.102.60+ 0.3018.80+ 1.10Reconstituted vesicles
02.50+ 0.302.40+ 0.60Lipid only
4.60+ 0.701.50+ 0.106.10+ 0.70Protein only
Table' 3.4. Reconstitution of nucleoside transport activity with crude octyl glucoside extract from
pig erythrocyte membranes and with partially-purified band 4.5 polypeptides. Uridine uptake by
vesicles (50 uM, 10 s flux at 25°C) was measured as described in the Methods section. In the prep-
aration of 'reconstitited vesicles', crude octyl glucoside extract and partially-purified band 4.5
polypeptides were reconstituted with added soybean phospholipids. Each transport assay contained 10
ug of protein and 0.3 umol of lipid (membrane extract) or 1.2 ug of protein and 0.3 umol of lipid
(band 4.5 preparation). For the 'lipid only' and 'protein only' controls, reconstitution was per-
formed in the absence of added protein and lipid, respectively. A is the difference in uridine
uptake in the presence and absence of 20 uM NBTGR. Values are means(+ SEM) of triplicate assays.
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band 4.5 polypeptides measured at 15'C (Table II, Tse
et al., 1985), the human transporter having a Q 10 of 4
(Young and Jarvis, 1983) in this temperature range.
Results presented in Table 3.4 demonstrate that the
NBTGR-sensitive transport activity of the crude membrane
preparation was strongly dependent upon the presence of
added phospholipid, membrane extract alone exhibiting 2%
of the NBTGR-sensitive uridine uptake of the reconstitut-
ed system. The higher basal NBTGR-sensitive uridine
transport activity of the partially-purified band 4.5
preparation (23%) (Table 3.4) is a consequence of its
higher phospholipid: protein ratio (see section 3.2.5a),
permitting vesicle formation and partial reconstitution
of transport activity even in the absence of added lipid
(Tse et al., 1985). Rates of NBTGR-insensitive uridine
uptake by the two reconstituted preparations ..were similar
to those given by liposomes alone (Table 3.5), indicating
that this component of uptake reflects simple diffusion
of isotopic permeant across the lipid bilayer. In
contrast to the partially-purified band 4.5 preparation,
neither of the other two pooled fractions from the DEAE-
cellulose. column (void-volume, 1 M NaCl) exhibited
detectable NBTGR-sensitive uridine transport activity
(data not shown). This result is in agreement with the
absence of NBMPR-binding activity from these fractions'
(Table 3.2).
In a final series of reconstitution experiments, the
crude octyl glucoside membrane extract was tested for
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stereospecific glucose transport activity. In contrast to
the equivalent human erythrocyte preparation, no
transporter-mediated uptake of glucose was detected, the




A previous attempt to isolate and purify a mammalian
nucleoside transporter focussed on the human erythrocyte
system (Jarvis and Young, 1981). In that cell type, the
nucleoside transporter co-purifies with other band 4.5
polypeptides (principally, the glucose transporter). The
approach employed in this Chapter towards obtaining a
more highly-enriched nucleoside transporter preparation
was to attempt purification from a different mammalian
species, the pig. Pig erythrocytes lack glucose transport
activity and utilise the nucleoside inosine as their
physiological energy source (Young et al., 1985 Kim and
McManus, 1971 Zeidler et al., 1976, 1985 Watts et al.,
1979 Kim et al., 1980). In vivo blockade of pig
erythrocyte nucleoside transport by NBMPR leads to a
rapid decline in intracellular [ATP] and a concommittant
increase in [ADP] (Young et al., 1986).
Initial attempts to isolate the pig erythrocyte
nucleoside transporter were hampered by the system's
unexpected behaviour during ion-exchange chromatography.
As illustrated in Table 3.1b, high affinity NBMPR-binding
activity was retained by DEAE-cellulose under conditions
in which the human erythrocyte nucleoside transporter are
eluted in the column void-volume. Step-wise elution with
I M NaCl released NBMPR-binding activity from the column,
but also eluted the anion-exchange transporter (band 3),
the major integral membrane protein present in' unpurified
membrane extracts. Isolation of the relevant band 4.5
62
polypeptides from pig erythrocyte membrane extracts was
then attempted by elution of the ion-exchange column with
a salt gradient to separate the NBMPR-binding protein
from band 3. In these experiments, the technique of
photoaffinity-labelling with radioactive NBMPR was used
to identify column fractions containing the NBMPR-binding
protein and to monitor the degree of purification
achieved. Only 5% of the NBMPR-binding sites in the
protein-depleted membranes used in a typical preparative
experiment were radiolabelled with[ 3 H]NBMPR. Since the
efficiency of photo-incorporation is approximately 15%
under the condition employed (Wu et al., 1983), the
actual fraction of nucleoside transporters covalently
labelled with[ 3H] NBMPR was 0.5%. Previous control
experiments with human erythrocyte membranes established
that the nucleoside transporter retains activity
following exposure to UV light (Wu et al., 1983).
In agreement with results presented in Chapter 2,
the radiolabelled pig erythrocyte NBMPR-binding protein
migrated on SDS-polyacrylamide gels with a significantly
higher apparent Mr than the human erythrocyte protein
(64,000 vs 55,000). This observation, together with the
different elution behaviour of the pig band 4.5 proteins
during DEAE-cellulose ion-exchange column chromatography,
provides evidence of significant molecular differences
between the NBMPR-binding proteins from the two, species.
In contrast, the rabbit erythrocyte NBMPR-binding protein
exhibits the same apparent Mr as that of the human system
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(Jarvis et al., 1986). Functionally, the pig and human
erythrocyte nucleoside transporters are indistinguish-
able. For example, in intact erythrocytes the two
transporters have similar affinities for NBMPR and
nucleoside permeants as well as equivalent turnover rates
for nucleoside translocation (Jarvis et al., 1980b). The
reconstituted nucleoside transporters from the two
species also exhibit similar properties (see Section
3.3.6 and Tse et al., 1985). However enzyme digestion
experiments with endoglycosidase-F and
endo- -galactosidase have provided evidence of both
carbohydrate and polypeptide differences between the
human and pig erythrocyte nucleoside transporters (see
Chapter 4).
In the gradient-elution procedure, [3H]NBMPR-
labelled protein eluted from the DEAE-cellulose column as
a nearly symmetrical peak at an NaCl concentration of
0.09 M, giving a preparation partiallt depleted in lipids
that was (i) active with respect to high-affinity
NBMPR-binding activity and (ii) catalysed NBMPR-sensitive
uridine transport when reconstituted into phospholipid
vesicles. Recovery of reversible NBMPR-binding activity
from the column (Table 3.2) was significantly less than
that for the radiolabelled protein, suggesting that the
isolated protein is relatively labile. A similar loss of
reversible NBMPR-binding activity occurs during partial-
purification of the human erythrocyte. nucleoside
transporter (Table 3.1a see also Jarvis and Young,
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1981). Octyl glucoside solubilisation of pig erythrocyte
protein-depleted membranes and subsequent column
chromatography resulted in a 60-fold purification of
radiolabelled NBMPR-binding protein. Since the initial
removal of extrinsic membrane proteins from erythrocyte
'ghosts' results in a 2.3-fold increase in specific
activity of NBMPR-binding (Table 3.1b and 3.2), the
overall purification achieved was 140-fold. Uridine
transport activity as assayed in reconstituted
phospholipid vesicles, co-purified with reversible
NBMPR-binding activity (Table 3.3), providing evidence
that the transport system was isolated in its entirety.
Parallel reconstitution/transport experiments with D- and
L-glucose confirmed the absence of glucose transporter
from the detergent extracts of pig erythrocyte membranes
(Fig. 3.17).
The final preparation contained two proteins,
detected as regions of •Coomassie Blue staining following
S DS -polyacrylamide gel electrophoresis. One region
migrated in the band 4.5 region of the gel at the same
position as the 3H-labelled pig transporter (apparent Mr
64,000), and the other migrated with a lower apparent
molecular weight of 43,000. The latter polypeptide
contributed 60% of the protein present in the preparation
as judged by absorbance scans and was not radiolabelled..
with [3 H]NBMPR, the small amount of H-activity in this
region of the gel being associated with a proteolytic
fragment of the nucleoside transporter (Wu et al., 1983
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Janmohamed et al., 1985). Thus the estimated purification
of radiolabelled NBMPR-binding protein with respect to
the Mr 64,000 band is estimated to be in the region of
350-fold. This value compares with a theoretical maxium
purification of 650-fold, calculated assuming a 1:1
stoichiometry for NBMPR-binding to the 64,000
polypeptide, or half that value (325-fold) if one
molecule of ligand binds to a 64,000 dimer (Jarvis
et al., 1980 Jarvis et al., 1984 Jarvis et al., 1986).
Therefore, it can be concluded that the NBMPR-binding
protein is one of the major polypeptide species present
in the 64,000 Coomassie Blue band.
The identity of the lower molecular weight species
present in the partially-purified band 4.5 preparation
remains to be resolved and we cannot at this stage
exclude the possibility that it plays some role in
nucleoside transport. This polypeptide is evidently
heavily glycosylated because endoglycosidase-F treatment
decreases its apparent Mr from 43,000 to 28,000 (see
Chapter Four). It is therefore likely to represent a
degradation product of a larger membrane protein,
possibly band 3. In the experienceof this laboratory, pig
erythrocyte band 3 is particularly susceptible to
endogenous proteolysis, even when PMSF is included in the
cell lysis buffer used to prepare erythrocyte ghosts..
Breakdown of 1% of the band' 3 present in solubilised
membrane extracts would be sufficient to account for the
material observed in the final band 4.5 preparation
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(T crone et al., 1979). An alternative possibility is that
the polypeptide is the pig equivalent of the human
erythrocyte glycoprotein of Hamaguchi and Cleve (1972).
The major membrane glycoprotein of pig erythrocytes has
been estimated to have an apparent molecular weight of
50,000 using a continuous phosphate buffer system
(Hamaguchi and Cleve, 1972).
In conclusion, the present experiments established
conditions for the substantial purification of the
NBTGR-sensitive nucleoside transporter from pig
erythrocytes, the results providing further evidence to
implicate band 4.5 polypeptides in nucleoside permeation.
It is expected that this highly- enriched nucleoside
transporter preparation will prove useful in molecular
studies of nucleoside transporter function and provide a
convenient starting point for further isolation studies.
One immediate application of the preparation has been as
immunogen for the production of monoclonal antibodies
directed against the pig erythrocyte nucleoside
transporter (Good, et al., 1986 see also Chapter Five).
Several antibodies that recognised pig erythrocyte band 3
polypeptides on western blots were also produced, further
evidence that the 43,000 polypeptide is a band 3
degradation product. Carbohydrate and polypeptide
differences between the partially- purified pig and human.
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ERYTHROCYTE NUCLEOSIDE TRANSPORTER PROTEINS
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4.1 Introduction
As detailed in the General Introduction and in
Chapter 2, the membrane proteins responsible for human
erythrocyte nucleoside and glucose transport co-migrate
as diffuse bands in the 4.5 region of SDS-polyacrylamide
gels (apparent Mr (average) 55,000). Data presented in
Chapter 2 and 3 demonstrate that the pig erythrocyte
nucleoside transporter is also a band 4.5' polypeptide,
but migrates on SDS-polyacrylamide gels as a sharper band
and with a higher apparent molecular weight than the
human erythrocyte nucleoside and glucose transporters
(apparent Mr (average) 64,000). In addition, the pig and
human erythrocyte, nucleoside transporters behave
differently during DEAE-cellulose ion-exchange
chromatography (Chapter 3).
The human erythrocyte glucose transporter polyp-
eptide is heterogeneously glycosylated. Partial or
essentially complete removal of oligosaccharide following
endo-A galactosidase or endoglycosidase- F treatment of
the isolated transporter results in (i) a sharpening of
its band on SDS-polyacrylamide gels, and (ii) shifts to
lower apparent molecular weight regions of the gel
(Cairns et al., 1984 Lienhard et al., 1984). In this
Chapter, these studies are extended to a comparison of
the effects of endo--galactosidase and endoglycosidase- F
digestion on the electrophoretic mobilities of partially-
purified preparations of human erythrocyte nucleoside and
glucose transporters. The effects of these enzymes on the
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pig erythrocyte NBMPR-binding protein were investigated
in an attempt to explore molecular differences between
the human and pig erythrocyte nucleoside transport
proteins. It is established that the human and pig
erythrocyte nucleoside transporters are both
glycoproteins containing, N-linked oligosaccharides. The
oligosaccharide and polypeptide structures from the two
sources are, however, different. This study also
demonstrates that the carbohydrate- depleted human
erythrocyte nucleoside and glucose transporters have
essentially identical mobilities on SDS-polyacrylamide
gels, further evidence of molecular similarities between
the two transport systems.
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4.2 Methods
4.2.1 Cell and membrane preparation
Fresh human and pig blood samples were collected
into heparin and processed as described in Chapter 2,
Section 2.2.1a. Protein-depleted membranes were prepared
from erythrocyte 'ghosts' as describes in Chapter 3,
Section 3.2.3a, and resuspended in solubilisation buffer
(see below).
4.2.2. Purification procedure
4.2.2a Human erythrocyte nucleoside and glucose
transporters
Purification of band 4.5 polypeptides from human
erythrocyte membranes was performed according to Chapter
3, Section 3.2.3. Briefly, protein-depleted membranes (2
mg protein/ml) were solubilised in 46 mM octyl glucoside
in 50 mM Tris-HC1, 2 mM DTT (pH 7.4 at 4°C) and 60 ml of
the 130,0002 supernatant applied at a flow rate of 85
ml/h to a 2.5x6.5 cm DEAE-cellulose, ion-exchange column
equilibrated with the same buffer. Void volume fractions,
which contained partially-purified band 4.5 proteins,
were pooled, dialysed free of detergent and concentrated
by ultracentrifugation (130,000g for 60 min). This
procedure resulted in a 19-fold purification of high
affinity [3H]NBMPR-binding activity. The specific
activity of NBMPR binding in the preparation used in this
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Chapter was 669 pmol/mg of protein, compared with 36
pmol/mg of protein for the starting human erythrocyte
ghosts. The major polypeptide species present in the
preparation was glucose transporter (Jarvis and Young,
1981 Baldwin et al., 1982). The preparation was stored
at -70°C.
4.2.2b Pig erythrocyte nucleoside transporter
preparation
As detailed in Chapter 3, the pig. nucleoside
transporter is adsorbed by DEAE-cellulose under
conditions where the human protein remains in the column
void-volume. Pig erythrocyte protein-depleted membranes
were therefore solubilised in in 46 mM octylglucoside,
2mM DTT in 5 mM Tris-HC1 (pH 7.4 at 4°C),, The DEAE-
cellulose ion-exchange column was equilibrated in this
buffer and eluted with 800m1 of a linear salt gradient
(0-0.2 M NaCl 46 mM octylglucoside, 2 mM DTT, 5mM
Tris-HC1). Fractions containing nucleoside transporter
protein (0.08-0.11 M NaCl) were pooled and treated as
described above for the human protein. The specific
activity of NBMPR binding in the final preparation was
1465 pmol of NBMPR bound/mg of protein compared with 23
pmol of NBMPR bound/mg of protein for the starting pig.




Photoaffinity labelling with [3H]NBMPR was carried
out as described in Chapter 2, Section 2.2.2b with minor
modifications. Partially-purified preparations of the
NBMPR binding protein (0.1 mg/ml final protein
concentration) were equilibrated at room temperature for
30min with a saturating concentration of[ 3H]NBMPR (50
nM). Samples were then cooled to 4°C and supplemented
with 50 mM DTT. Photolysis was carried out in quartz 0.4
ml spectrometer cuvettes (1 mm light path) at 4°C using a
450-watt mercury arc lamp. UV exposure was for 45 s at a
distance of 6.5 cm from the lamp's silica cooling sleeve.
Samples were then diluted 20-fold with 5P8 and allowed to
stand at room temperature for 10 min before recovery of
radiolabelled transporter by ultracentrifugation
(130,0002, 60 min). The washed pellets were resuspended
in the appropriate enzyme digestion buffer (see below).
4.2.3b [3H]Cytochalasin B
The procedure used to covalently photolabel the
human erythrocyte glucose transporter with
[3H]cytochalasin B was similar to that for photolabelling..
with NBMPR. Band 4.5 polypeptides (0.1 mg/ml final
concentration) in 500 mM D-sorbitol or D-glucose (to
correct for non- specific labelling) were incubated with
0.8 uM[ 3H]cytochalasin B (17 Ci/mmol). for 30 min on ice
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before photoactivation for 45 s. Unbound radioligand was
removed by the same procedure described in the previous
section.
4.2.4 Enzyme digestion
4.2.4a Endo -,B- galactosidase digestion
Treatment of the radiolabelled transporter
preparations (0.1 mg protein/ml) with endo-p-galactosid-
ase was carried out at 37°C for 18 h with agitation in 50
mM sodium phosphate (pH 6.0), 1 mM DTT and 1 mM EDTA,
using an enzyme concentration of 0.25 units/ml (Cairns
etal., 1984). Reaction was terminated as described in the
next section.
4.2.4b Endoglycosidase-F digestion
Treatment with endoglycosidase F (0.4 units/ml) was
carried out at 22°C for 18 hours with agitation in 100mM
sodium phosphate (pH6.0) containing fi-mercaptoethanol
75mM, 50mM EDTA, 0.5% (w/v) Triton X-100, 0.05% (w/v) SDS
and 0.lmg transporter protein/mi. Both enzymatic
digestions were terminated by addition of equal volume of
SDS-polyacrylamide gel sample buffer containing 100mM
Tris-HC1 (pH6.8), 2mM EDTA, 75mM DTT, 10% (w/v) SDS, 20%
(w/v) glycerol and 0.004% Bromophenol Blue (Lienhard.
etal., 1984).
4.2.5 SDS-polyacrylamide gel electrophoresis
SDS -polyacrylamide gel electrophoresis was carried
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out in 2mm thick 10% slab gels as described in Chapter 2
Section 2.2.2d. Staining with Coomassie Blue and
processing of gel samples for liquid scintillation
counting were also performed as described in Chapter 2.
4.2.6 Protein determination




4.3.1 Photoaffinity labelling of partially purified
human and pig erythrocyte band 4.5 proteins
Exposure of human erythrocyte band 4.5 polypeptides
to UV light in the presence of [3 H]NBMPR or[ 3H]cyto-
chalasin B under equilibrium binding conditions resulted
in substantial radiolabelling of nucleoside and glucose
transporter polypeptides, respectively. As shown in Fig.
4.1, the major peaks of radiolabelling were located in
the band 4.5 region of the gel and co-migrated with the
single broad band of Coomassie Blue staining evident in
the gels (apparent Mr (average) 55,000) (Fig. 4.2, lanes
1 and 14). The majoroty of this Coomassie Blue-stained
protein is glucose transporter (Jarvis and Young, 1981
Baldwin et al., 1982). In agreement with previous
photoaffinity labelling experiments with intact membranes
(Chapter 2, Section 2.3.5 and Chapter 3, Section 3.3.4
Young et al., 1985), the radiolabelled NBMPR binding
protein in the pig erythrocyte band 4.5 preparation
migrated. as a sharper peak and with a higher apparent
molecular weight than the human erythrocyte NBMPR binding
protein (Fig. 4.3). Similarly, the small amount of
radiolabelled proteolytic degradation product present in
the pig partially-purified preparation also migrated with
a higher apparent Mr than the corresponding human
cleavage product (see also next Chapter). Radiolabelling
of both the human and pig erythrocyte nucleoside
Fig. 4.1 Photoaffinity labelling of human erythrocyte
nucleoside and glucose transporter polypeptides
with [3H]NBMPR and [3 H]cytochalasin B.
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Human erythrocyte band 4.5 polypeptides were photo-
affinity labelled with[ 3 H]NBMPR and[ 3 H]cytochalasin B
as described in 'Section 4.2.3 and subjected to SDS-
polyacrylamide gel electrophoresis. 3 H-Profiles for the
glucose (0) and nucleoside transporters (0)(10ug membrane
protein) and positions of molecular weight standards are
from the same slab gel. The positions of the stacking
gel-running gel interface and the tracking dye are
indicated by a and. b, respectively.
3H-Activity(cpm*10-3)
Fig. 4.2 Effects of endo- -galactosidase and endo-
glycosidase-F digestion on the electrophoretic
profiles of band 4.5 polypeptides isolated from
human and pig erythrocyte membranes.
Isolated band 4.5 polypeptides were treated with either
endo- -galactosidase or endoglycosidase-F as.. detailed in
the text, subjected to SDS-polyacrylamide gel electre-
phoresis and stained with Coomassie blue. Lanes were
loaded with lOug human protein or 30ug pig protein. Lanes
1 and 14, human band 4.5. Lanes 7 and 8, pig band 4.5.
Lanes 2 and 6, human and pig band 4.5, respectively,
incubated for 18h at 22°C in digestion buffer without
endoglycosidase-F. Lanes 3 and 5, human and pig band 4.5,
respectively, treated with endoglycosidase-F. Lane 4,
endoglycosidase-F (0.4 units). Lanes 9 and 13, pig and
human band 4.5 incubated for 18h at 37°C in digestion
buffer without endo-B-galactosidase. Lanes 10 and 12, pig
and human band 4.5, respectively, treated with endo- -
galactosidase. Lane 11, endo- A -galactosidase (0.0125
units) stabilised with 3ug bovine serum albumin. Figures
on the left refer to positions of molecular weight
standards. The positions of the stacking gel-running gel
interface and the tracking dye are indicated by a and b,
respectively.









Fig. 4.3 Photoaffinity labelling of human and pig
erythrocyte nucleoside transporter polypeptides
with [3H]NBMPR.
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Partially-purified preparations of the two transporters
were photoaffinity labelled with[ 3H]NBMPR as described
in Section 4.2.3a and subjected to SDS-polyacrylamide gel
3
electrophoresis. H-Profiles for the human (0) and pig
preparations(•) (lOug membrane protein) and positions of
molecular weight standards are from the same $lab gel.
The positions of the stacking gel-running gel interface













transporters was abolished when photolysis was performed
in the presence of 20uM NBTGR as the competing
nonradioactive ligand (data not shown).
Unlike the human preparation, the partially-purified
nucleoside transporter preparation from pig erythrocytes
exhibited two regions of Coomassie Blue staining (Fig.
4.2, lanes 7 and 8), one migrating in the same position
as the H-labelled pig transporter (apparent Mr (average)
64,000), the other with a lower apparent molecular weight
(apparent Mr (average) 43,000) (see also.. Chapter 3,
Section 3.3.4). The latter protein contributed to about
60% of the protein present in the preparation as judged
from absorbance scans and was not radiolabelled with
OH]NBMPR, the small amount of 3H in this area of the gel
being associated with a proteolytic fragment of the
nucleoside transporter (see above). As discussed in
Chapter 3, the nucleoside transporter is one of the major
polypeptide species present in the 64,000 daltons
Coomassie Blue-stained band.
4.3.2 Endo -,B-galactosidase treatment
Fig. 4.4 compares the SDS-polyacrylamide gel 3 H-
profiles of the radiolabelled human erythrocyte nucleo-
side transporter incubated for 18h at 37°C either in the
absence or in the presence of endo- -galactosidase.
Enzyme treatment resulted in a significant sharpening- of
the 3 H-peak and an increase in electrophoretic mobility.
Values of apparent Mr obtained in this and subsequent
Fig. 4.4 Effect of endo-p-galactosidase on the electro-
phoretic mobility of the human erythrocyte
nucleoside transporter.
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Transporter preparation radiolabelled with[ 3H]NBMPR was
incubated for 18h at 37°C either in the presence (0)' or
in the absence (0) of enzyme and electrophoresed as
described in the text. 3 H-Profiles and positions of Mr
standards are from the same slab gel. Positions of the
stacking gel-running gel interface and the tracking dye




experiments are summarised in Table 4.1. As shown in Fig.
4.4, the 3H-labelled proteolytic cleavage product also
increased in electrophoretic mobility after endo- -
galactosidase digestion, providing evidence that this
fragment of the transporter contains carbohydrate. As
expected from previous studies (Cairns et al., 1984)
endo- -galactosidase produced a parallel change in the
electrophoretic mobility of Coomassie Blue-stained band
4.5 protein (Fig. 4.2, lane 12). The sharp protein band
observed in endo-A -galactosidase-treated. samples at
apparent Mr 66,000 is bovine serum albumin (included to
stabilise the lyophilised enzyme preparation) (Fig. 4.2,
lane 11). A parallel experiment directly comparing the
electrophoretic mobilities of the endo- -galactosidase-
treated human erythrocyte nucleoside and glucose
transporters is presented in Fig. 4.5. The results
establish a close, but not exact, correspondence in
apparent Mr for the two enzyme-treated transporters
(Table 4.1). In contrast to its effects on the human
erythrocyte nucleoside and glucose transporters, endo- -
galactosidase digestion under identical conditions had no
measurable effect on the electrophoretic mobility of the
radiolabelled pig erythrocyte nucleoside transporter
(Fig. 4.6). Similarly, there was no effect on the
electrophoretic mobilities of the two Coomassie Blue-
stained bands present in the pig preparation (Fig. 4.2,
lane 10).
Fig. 4.5 Effects of endo-P-galactosidase on the electro-
phoretic mobilities of the human erythrocyte
nucleoside and glucose transporters.
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Band 4.5 polypeptides radiolabelled with [3 H]NBMPR ()
and [3H]cytochalasin B (0) were incubated for 18h at 37°C
in the presence of enzyme and subjected to SDS-
polyacrylamide gel electrephoresis as described in the
text. 3 H-Profiles and positions Mr standards are from the
same slab gel. Positions of the stacking gel-running gel




Fig. 4.6 Effect of endo-p-galactosidase on the electro-
phoretic mobility of the pig erythrocyte
nucleoside transporter.
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Transporter preparation radiolabelled with[ i]NBMPR was
incubated for 18h at 37°C either in the presence (p) or
in the absence (4) of enzyme and electrophoresed as
described in the text. 3 H-Profiles and positions of Mr
standards are from the same slab gel. Positions of the
stacking gel-running gel interface and the tracking dye




Endo-A -galactosidase hydrolyses internal -galacto-
sidase 'linkages of oligosaccharides belonging to the
poly-N-acetyllactosamine series. In a second series of
experiments, the effects of endoglycosidase-F was
studied. This enzyme cleaves the glycosidic bond of
N-acetylglucosamine (1-4) N-acetylglucosamine linked to
asparagine of core proteins bering high mannose
structures. Figs. 4.7 and 4.8 compare the SDS-polyacryl-
amide gel 3H-profiles of radiolabelled human and pig
erythrocyte nucleoside transporters incubated (18h, 22°C)
in the absence and in the presence of endoglycosidase-F.
In contrast to endo--galactosidase, endoglycosidase-F
digestion affected the electrophoretic mobilities of both
the human and pig erythrocyte nucleoside transporters. In
each case there was a significant sharpening of the 3 H-
peak and a shift to a lower apparent molecular weight,
the human protein showing the larger decrease in Mr
(Table 4.1). The electrophoretic mobilities of both the
human and pig degradation 3 H-peaks were also shifted to
lower molecular weight regions of the gel, again an
indication that these polypeptide fragments are
glycosylated.
As shown in Fig. 4.9 and summarised in Table 4.1,
there was again a close, but not exact, correspondence
between the electrophoretic mobilities of the. human [3 H]-
NBMPR-labelled nucleoside transporter and[ 3 H]cytochala-
sin B-labelled glucose transporter after endoglycosidase-
Table 4.1 Apparent molecular weights of erythrocyte
nucleoside and glucose transport polypeptides
treated with endo-- galactosidase and endo-
glycosidase- F.
Control Endo-p-treated Endo- F-treated
Glucose
transporter 55,000 48,000 45,000
(human)
Nucleoside
transporter 55,000 47,000 44,000
(human)
Nucleoside
transporter 64,000 64,000 57,000
(pig)
Values are mean results from two independent experiments.
See text and Figs. 4.3 and 4.4 for experimental details.
The small difference in electrophoretic mobility of the
endoglycosidase- F-treated human glucose and nucleoside
transporters was confirmed in two additional experiments.
Fig. 4.7 Effect of endoglycosidase-F on the electro-
phoretic mobility of the human erythrocyte
ncleoside transporter.
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Transporter polypeptide radiolabelled with[ 3 H]NBMPR was
incubated for 22°C either in the presence(•) or in the
absence (0) of enzyme and electrophoresed as described in
the text. 3H-Profiles and positions of Mr standards are
from the same slab gel. Positions of the stacking
gel-running gel interface and the tracking dye are
indicated by a and, b, respectively.
3H-Activity(cpm*10-3)
Fig. 4.8 Effect of endoglycosidase-F on the electro-
phoretic mobility of the pig erythrocyte
nucleoside transporter.
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Transporter polypeptide radiolabelled with[ H]NBMPR was
incubated for 18h at 22°C either in the presence(•) or
in the absence (0 of enzyme and electrophoresed as
described in the text. 3H-Profiles and positions of Mr
standards are from the same slab gel. Positions of the
stacking gel-running gel interface and the tracking dye
are indicated by a and b, respectively.
3H-Activity(npm*10-3)
Fig. 4.9 Effects of endoglycosidase-F on the electro-
phoretic mobilities of the human erythrocyte
nucleoside and glucose transporters.
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Band 4.5 polypeptides radiolabelled with [3H]NBMPR (0)
and [3H]cytochalasin B (0) were incubated for 18h at 22°C
in the presence of enzyme and subjected to SDS-
polyacrylamide gel electrophoresis as described in the
text. 3H-Profiles and positions of Mr standards are from
the same slab gel. Positions of the stacking gel-running




F digestion, a result similar to the previous endo--
galactosidase experiments (Fig. 4.5). As expected, the
H-peak associated with the carbohydrate-depleted glucose
transporter exactly co-migrated with endoglycosidase-F-
treated band 4.5 (Fig. 4.2, lane 3). Similarly, the
H-peak associated with the endo-glycosidase-F-treated
pig nucleoside transporter co-migrated with the high
molecular weight band of Coomassie Blue staining present
in the preparation (Fig. 4.2, lane 5). The 43,000 dalton
protein present in the pig nucleoside transporter
preparation had an apparent Mr of 28,000 after
endoglycosidase-F digestion. Endoglycosidase-F present in
the samples (0.4 units) was not detected by Coomassie
blue staining (Fig. 4.2, lane 4). Aggregation of the
radiolabelled human erythrocyte glucose and nucleoside
transporters was more severe than in the
t
endo-JS-galactosidase experiments, possibly reflecting the




The experiments presented in this Chapter demons-
trate that the human and pig erythrocyte nucleoside
transporters are both glycoproteins containing N-linked
oligosaccharide. The observation that (i) the pig
nucleoside transporter is resistant to endo- -galactosid-
ase digestion, and (ii) endoglycosidase-F treatment had a
more pronounced effect on the apparent Mr of the human
nucleoside transport protein provide evidence of a marked
species difference in the structures of. the oligo-
saccharide present on the two transporter polypeptides.
Carbohydrate differences between the human and pig
erythrocyte nucleoside transporters might, in part,
account for the different electrophoretic mobilities of
the native proteins on SDS-polyacrylamide gels and their
different elution profiles during DEAE-cellulose ion-
exchange chromatography. The finding that endoglycosid-
ase-F treatment increased the difference in apparent Mr
between the human and pig erythrocyte nucleoside
transporters (13,000 after enzyme digestion compared with
9,000. before) (Table 4.1) is evidence that there is also
a major polypeptide difference between the two
transporters. This latter conclusion relies on the
assumption that endoglycosidase- F removed the majority of
carbohydrate attached to the pig protein.
Photoaffinity labelling experiments with [3H]NBMPR
have established that NBMPR-binding protein with apparent
molecular weight. similar to the corresponding human
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erythrocyte protein (55, 000) are present in rabbit
erythrocytes (Jarvis et al., 1986), various guinea pig
tissues (Kwan and Jarvis, 1984 Shi et al., 1984 Wu
et al., 1984 Jarvis and Ng, 1985) and mouse S49 lymphoma
cells (Young et al., 1984). Interestingly, rat
erythrocyte NBMPR binding protein has a higher apparent
Mr (average) in the region of 60,000 (Shi et al., 1984
Wu et al., 1984), while the Novikoff rat hepatoma NBMPR
binding protein has an apparent Mr of 72,000-80,000 (Gati
et al., 1986). In contrast to the human/pig difference
described in the present Chapter, the difference in
apparent Mr between the guinea pig and rat liver
nucleoside transporters is abolished after endo-
glycosidase-F digestion (Baldwin, S.A., Wu, J-S. and
Young, J.D., unpublished observation).
The present results also provide further evidence of
molecular similarities between the human erythrocyte
nucleoside and glucose transporters, the native proteins
having indistinguishable electrophoretic mobilities on
SDS-polyacrylamide gels. More significantly, the
deglycosylated polypeptides exhibited almost identical
apparent molecular weights of 44,000 and 45,000,
respectively. As detailed in the General Introduction and
elsewhere (Jarvis and Young, 1981 Wu et al., 1983a Wu
et al., 1983b Young et al., 1985) there are important
functional and physiological similarities between the two
transport systems. The correspondence in apparent Mr may
therefore not be co-incidental and is perhaps an
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indication of some degree of structural homology between
the two prateins. With regard to possible sites of
glycosylation, the recently determined amino acid
sequence of the human HepG2 hepatoma glucose transporter
contains two asparagine residues, one of which (Asn411)
is located within a postulated membrane-spanning domain
of the transporter (Muekler etal., 1985). The other
asparagine residue (Asn45) has been shown to be
glycosylated in vitro (Muekler etal., 1985), and its
location is consistent with the site of glycosylation of
the erythrocyte glucose transporter determined by enzyme
and chemical cleavage studies (Cairns, etal., 1984).
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Results presented in Chapter 4 have established that
the human and pig erythrocyte nucleoside transporters are
both glycoproteins, but that the transporters from these
two species exhibit substantial polypeptide and
carbohydrate differences. This Chapter describes a series
of experiments using proteolytic enzymes and
endoglycosidase F to treat[ 3H]NBMPR-radiolabelled ghosts
and right-side-out membrane vesicles. The objectives of
these experiments were (a) to study the transmembrane
topology of the transporters and (b) to further explore
the nature of the molecular differences between the pig
and human transport proteins.
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5.2 Methods
5.2.1 Cell and membrane preparation
Human and pig erythrocyte ghosts were prepared from
freshly drawn blood as described in Chapter 3, Section
3.2.1.
5.2.2 Photoaffinity labelling
Photoaffinity labelling of human and pig erythrocyte
ghosts with[ 3 H]NBMPR was carried out as described in
Chapter 2, Section 2.2.2b.
5.2.3 Right-side-out vesicles (ROVs)
5.2.3a Vesicle preparation
Right-side-out membrane vesicles were prepared
according to the procedure of Steck and Kant (1974) as
modified by Cohen and Soloman (1976).[ 3H]NBMPR-labelled
ghost membranes (5 ml, 4 mg protein/mi) prepared as
described in Chapter 2, Section 2.2.2b were diluted to
120 ml with 0.5 mM sodium phosphate (pH 8.0), and left on
ice for 30 min. At the end of this time, 200 mm MgC12 was
added to the suspension to give a final MgCl 2 concentra-
tion of 0.1 mM. Membranes were then pelleted by centrifu-
gation (30,0002, 1 h) and the pellet kept at 4°C over-
night. After overnight incubation, the membrane pellet
was resuspended in 2 mi of 0.1 mM MgCl, 0.5 mM sodium
phosphate (pH 8.0). The suspension was then homogenised
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by 5 passages through a 27 gauge needle, and afterwards,
was diluted into 5 ml of the same solution. This diluted
suspension of vesicles was layered onto 8.5 ml of Dextran
T-70 barrier solution (4.5% (w/v) Dextran T-70, 0.1 mM
MgC12, 0.5 mM sodium phosphate, pH 8.0) in a 13.5 ml
Beckman SW-40 centrifuge tube and centrifuged at 30,0008
for 4 h. Sealed right-side-out vesicles were recovered
from the barrier interface, washed twice in 5 mM sodium
phosphate, pH 8.0, and finally resuspended in the same
buffer or in 150 mM NaCl, 5 mM sodium phosphate (pH 8.0).
5.2.3b Vesicle sidedness assay
Vesicle sidedness was established by determining the
accessibility of glyceraldehyde-3-phosphate dehydrogen-
ase, a marker for the intracellular membrane surface, as
described by Steck and Kant (1974). Briefly, right-side-
out vesicle suspensions were diluted to 50 ug protein/ ml
with 5P8 or 150 mM NaCl, 5 mM sodium phosphate (pH 8.0)
in the presence or in the absence of Triton X-100 (0.1%
(v/v) final concentration), then 200 ul of this
suspension was added to the bottom of a 1 ml cuvette,
followed by 0.62 ml sodium pyrophosphate (30 mM, pH 8.4),
30 ul of sodium arsenate (0.4 M) and 50 ul of fl -NAD (20
mM). Finally, 100 ui of D,L-glyceraldehyde (15 mM, pH
7.0) was added. The cuvette was mixed by inversion and
placed in a recording spectrometer. An increase in
absorbance of 6.22 at 340 nm corresponded to 1 umole of
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NADH generated and the enzyme activity in unsealed ghosts
at room temperature was in the region of 2.5 umol/min per
mg of protein. The ROV preparations were typically 95%
pure.
5.2.4 Enzymatic digestions
Enzyme treatment was performed after photolysis in
solutions containing ghosts or ROVs in the appropriate
isotonic (150 mM NaCl, 5 mM sodium phosphate, pH 8.0) or
hypotonic (5mM sodium phosphate, pH 8.0) buffers. The
digestion volume was 1 ml in all cases, and the membrane
protein concentration was 1 mg/ml.
5.2.4a Trypsin
Human and pig erythrocyte 'ghosts' and ROVs in
isotonic and hypotonic buffers were incubated with
different amounts of trypsin (0.5-50 mg/ml) for 15 min at
1'C (Jarvis etal., 1985). Proteolysis was stopped by the
addition of 20 volumes of isotonic or hypotonic buffers
containing 0.3mM PMSF followed by centrifugation at
350009 for 30 min. The pellets were washed once more in
PMSF-containing medium and then dissolved in gel sample
buffer (Chapter 2, Section 2.2.2d), or, in endoglycosidase
F digestion buffer (see Section 5.2.4f).
5.2.4b oC- Chy motry psin
Digestion was carried out at 37°C for 90 min in
isotonic or hypotonic buffer with different cocentrations
of a -chvmotrvpsin (1-10 units/lml) as described by
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Shanahan and D'Artell-Ellis, (1984). Proteolysis was
terminated as described above (Section 5.2.4a).
5.2.4c Thermolysin
Digestion (0.1-10 units/ml) was carried out at 3T C
for 30 min in isotonic or hypotonic buffer supplemented
with 5mM calcium chloride to enhance the stability of the
enzyme. Reaction was stopped by the addition of 20
volumes of the appropriate calcium-free buffers also
containing 5 mM EDTA. 'Ghosts' and ROVs were. washed once
more. and recovered as described in Section 5.2.4a.
5.2.4d Leucine amino peptidases -M and -C
Digestions with leucine amino peptidase M
(microsomal) and leucine amino peptidase C (cytosolic)
(1-5 units/ml) were carried out at 37°C for 90 min in the
absence or in the presence of 5 mM MgC1 (to stabilise
leucine amino peptidase C), respectively. Reaction was
stopped by addition of 20 reaction volumes of ice-cold
buffer containing 0.5% (w/v) bovine serum albumin and
processed for SDS-polyacrylamide gel electrophoresis as
described in Section 5.2.4a.
5.2.4e Carboxypeptidases
Treatment of membrane 'ghosts' and ROVs with
carboxypeptidases A. B and Y was carried out in the same
isotonic and hypotonic buffers as described above for
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trypsin (Section 5.2.4a) except that the pH of the
carboxypeptidase Y digestion buffers was changed to pH
6.0, the optimum pH for this enzyme. Digestions were
carried out at 37'C for 90 min with 2.4 units of
enzyme/ml (Shanahan and D'Artel-Ellis, 1984). Reaction
was terminated as described in Section 5.2.4d.
5.2.4f Endoglycosidase-F
In some experiments, trypsin-treated 'ghosts' were
further digested with endoglycosidase-F as,. described in
Chapter 4, Section 4.2.4b.
5.2.5 SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis was carried
out in 2 mm thick 12% slab gels as described in Chapter
2, Section 2.2.2d. Processing of gel samples for liquid
scintillation counting was also performed as described in
Chapter 2, Section 2.2.2d.
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5.3 Results
5.3.1 Digestion with trypsin
Digestion of [3H]NBMPR-photolabelled human
erythrocyte ghosts with trypsin (0.5-5.0 ug enyzme/mg of
membrane protein, 15 min at 1'C) in isotonic or hypotonic
buffer generated two radioactive fragments with Mr values
of 38,000 and 23,000 (Fig.5.1). The quantity of the Mr
23,000 fragment increased as the concentration of trypsin
increased and there was a corresponding.. decrease of
radioactivity associated with the Mr 38,000 polypeptide
(Fig. 5.1). It is therefore likely that the Mr 38,000
polypeptide is the precursor of the Mr 23,000 fragment.
These results confirm the data presented by Jarvis et al.
(1986), but are different from those reported by
Janmohamed et al., (1985) in which the 23,000 fragment
migrated as a considerably narrower peak. Digestion of
pig erythrocyte 'ghosts' with trypsin (5-50 ug enzyme/ml)
produced radioactive fragments similar to those from
human 'ghosts', but with significantly higher apparent
molecular weights (apparent Mr 42,000 and 24,000,
respectively) (Fig.5.2). This cleavage pattern for pig
membranes has subsequently been confirmed by Good etal.,
(1986). Both the high and low molecular weight fragments
from human and pig erythrocyte ghosts migrated as
relatively broad peaks, suggesting the presence.. of
carbohydrate. Although the human and pig cleavage
patterns were, qualitatively similar, the results

Fig. 5.1 Trypsin digestion of [ 3 H]NBMPR-labelled human
erythrocyte membranes.
Human erythrocyte membranes were photolabelled with [3H]
NBMPR as described in Chapter 2, Section 2.2.2b, then
treated with 0.5 ug (B) and 5.0 ug (C) of trypsin in
isotonic or hypotonic (D, 0.5 ug) buffers for 15 min at
1°C as described in Section 5.2.4a. The control
incubation (A) contained no trypsin. The trypsin-treated
membranes (100 ug) were electrophoresed on 12% acrylamide
gels as described in Chapter 2, Section 2.2.2d. The
position of the stacking gel- running gel interface and
the tracking dye are represented by a and b respectively.
66K, for example, 66,000. In this and subsequent
experiments the incubation volume was 1 ml.
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presented in Figs 5.1 and 5.2 demonstrate that the human
transporter was approximately 10-fold more sensitive to
enzyme treatment than the pig protein.
Results presented in Figs. 5.1 and 5.2 further
demonstrate that the trypsin digestion profiles (0.5 ug
enzyme/ml (human) and 5 ug enzyme/ml (pig) )were
unaffected by the buffer composition (150mM NaCl, 5 mM
sodium phosphate pH 8.0 or 5P8).
Trypsin treatment of human and pig right-side-out
membrane vesicles (ROVs) under both isotonic.. or hypotonic
conditions resulted in little apparent loss of label from
the band 4.5 region, and only minor radiolabelled
fragments were detected (Figs. 5.3 and 5.4). Thus, there
are no- trypsin-cleavage sites available on the outer
surface of the two nucleoside transporter proteins.
5.3.2. Endoglycosidase-F digestion of trypsinised human
and pig erythrocyte membranes
To further investigate the molecular weight
difference between the human and pig erythrocyte
nucleoside transporters, trypsinised human and pig
erythrocyte membranes (0.5 ug/ml and 5 ug/ml trypsin,
respectively) were subjected to. endoglycosidase, F
digestion. Before treatment, the human and pig
transporter fragments ran as broad bands at Mr (average)
38,000 and 42,000, respectively (see also Section 5.3.1).
After endoglycosidase F treatment, the apparent Mr values
of these fragments decreased from Mr 38,000 to 30,000
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Experimental conditions were the same as in Fig. 5.1. A,
control B. 5.0 ug trypsin in isotonic buffer C, 50 ug




Fig. 5.3 Trypsin digestion of[ 3H]NBMPR-labelled human
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Membranes photolabelled with[ 3H]NBMPR were converted
into ROVs as described in Section 5.2.3 and treated with
trypsin for 15 min at 1°C in isotonic buffer conditions.






Fig. 5.4 Effects of isotonic and hypotonic buffer


























Experimental procedures were the same as in Fig. 5.3. A,
control; B, 5.0 ug trypsin in isotonic buffer; C, 5.0 ug












Trypsin treated (15 min, 1°C)








Table 5.1 Apparent molecular weight values for human
and pig erythrocyte nucleoside transport polypeptides
treated with endoglycosidase-F (Endo-F) and trypsin and
a combination of both. Values are means results from two
independent experiments, (see Figs. 5.6, 5.7 and Table
4.1).
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(human) and from 42,000 to 37,000 (pig) (Figs. 5.5 and
5.6). Results from these experiments are summarised
together with the endoglycosidase F results from Chapter
4 in Table 5.1.
5.3.3 Digestion with chymotrypsin
Human erythrocyte ghosts were less sensitive to
chymotrypsin digestion under isotonic conditions than
under hypotonic buffer conditions (Fig. 5.7). In
hypotonic buffer, two radiolabelled fragments were
obtained, one broad peak at Mr (average) 22,000 and
another sharper peak at Mr 14,000 (Fig. 5.7, panel B).
Under isotonic conditions, the Mr 22,000 peak was the
major peak of radiolabelling (Fig. 5.7, panel C). In
contrast, medium ionic strength had little effect on the
radioactive cleavage pattern obtained with human ROVs
treated with chymotrypsin (Fig. 5.8). The degree of
degradation in ROVs was perhaps less severe than with
unsealed 'ghosts' under both conditions. This suggests
that there are chymotrypsin cleavage sites on both sides
of the membrane but that in ROVs the internal sites were
protected from the enzyme. If cleavage sites were only
present on the exofacial part of the transporter, then
the radioactive patterns in 'ghosts' and ROVs would have
been identical (see Section 5.3.4).
Different chymotryptic digestion patterns were ..also
observed when pig unsealed ghosts were compared with ROVs
(Fig. 5.9) under isotonic conditions, again, suggesting
Fig. 5.5 Effects of trypsin and endoglycosidase F
digestion on[ 3H]NBMPR-labelled human erythro-
cyte membranes.











[ 3H]NBMPR-radiolabelled membranes were first treated with
trypsin (see Fig. 5.1) and subsequently with endo-
glycosidase F (1.0 unit, for' 16 h at 22°C) (see Section
5.2.4f for details). A, control, incubations in the
absence of trypsin and endoglycosidase F B, trypsin





Fig. 5.6 Effects of trypsin and endoglycosidase F
digestion on[ 3H]NBMPR-labelled pig erythrocyte
membranes.
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Experimental procedures were the same as in Fig. 5.5. A,





Fig. 5.7 Effects of chymotrypsin on [3H] NBMPR-labelled
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[ 3H]NBMPR-labelled membranes were incubated with 10 units
of chymotrypsin at 37°C for 90 min in isotonic (C) or
hypotonic (B) buffers. A, membranes incubated in the
absence of enzyme.
Fif. 5.8 Effects of chymotrypsin on [H] NBMPR-labelled
human erythrocyte right-side-out vesicles
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Experimental procedures were the same as in Fig. 5.7. A,
control; B, ROVs in hypotonic buffer; C, ROVs in isotonic
buffer. •
Fig. 5.9 Effects of chymotrypsin on [H] NBMPR-labelled
pig erythrocyte membranes and right-side-out
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Experimental procedures were the same as in Fig. 5.7. A,
control; B, membranes treated with 10 ug enzyme; C, ROVs
treated with 10 ug enzyme.
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that chymotrypsin cleavage sites are present on both
sides of the membrane.
5.3.4 Digestion with thermolysin
Thermolysin, like chymotrypsin, preferentially
cleaves at hydrophobic amino acids but on the N-terminal
side. It was expected that the cleavage patterns would be
similar to those obtained with chymotrypsin. However,this
was not the case. Thus, enzyme digestion of 'ghosts' and
ROVs gave similar patterns in both species ..(human, Figs.
5.10 and 5.11 pig, Figs, 5.12 and 5.13), suggesting that
thermolysin largely cleaves the human and pig erythrocyte
nucleoside transporters at the exofacial membrane
surface.
5.3.5 Digestion with amino peptidases and
carboxypeptidases
To investigate the location of the N- and
C-terminals in relation to the transmembrane disposition
of the transporter, two aminopeptidases- leucine amino
peptidase M (microsomal) and leucine amino peptidase C
(cytosol) and three exopeptidases, carboxypeptidase A, B
and Y were used. If the N- and C-terminals are accessible
to enzymatic degradation by these enzymes and if
sufficient residues are cleaved, then a shift in
electrophoretic mobility of the radiolabelled_ transporter
might be observed. In addition, the membrane locus of
such a digestion should be revealed by a comparision of
Fig. 5.10 Effects of thermolysin on [3HjNBMPR-labelled
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[ 3H]NBMPR-labelled membranes were incubated in the
absence (A) and in the presence of 1.0 unit (B), and 10.0
units (C) of thermolysin for 30 min at 37°C.
Fig. 5.11 Effects of thermolysin on[ H]NBMPR-labelled
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Experimental procedures were the same as in Fig. 5.10. A,
control incubation; B, 1.0 unit enzyme; C, 10.0 units
enzyme.
Fig. 5.12 Effects of thermolysin on [3H]NBMPR-labelled
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Experimental procedures were the same as in Fig. 5.10. A,
control incubation; B, 1.0 unit enzyme, C, 10.0 units
enzyme.
Fig. 5.13 Effects of thermolysiri on [3H]NBMPR-labelled
pig erythrocyte right-side-out vesicles under
isotonic buffer conditions.
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Experimental conditions were the same as in Fig. 5.10. A,














Representative experiments of the effects of these
enzymes on the human and pig erythrocyte nucleoside
transporters are shown in Figs, 5.14 and 5.15,
respectively. In no case was significant movement of the
band 4.5 radioactive peak observed.
Fig. 5.14 Effects of carboxypeptidase Y and leucine amino
peptidase-M on[ H]NBMPR-labelled human






























[ H]NBMPR-labelled membranes were incubated with 2.4
units of carboxypeptidase Y (B) and 1.5 units of leucine
amino peptidase-M (C) at 37°C for 90 min. A, membranes
incubated in the absence of enzyme.
Fig. 5.15 Effects of carboxypeptidase Y and leucine amino
peptidase-M on[ 3H]NBMPR-labelled pig erythro-
cytre membranes under isotonic conditions.
















Experimental procedures were the same as in Fig. 5.14. A,
control incubation; B, 2.4 units carboxypeptidase Y; C,













In the experiments with trypsin, the following
conclusion were reached.
(a) The human and pig transporters are not
susceptible to tryptic proteolysis from the extracellular
surface of. the membrane, but are cleaved at the
cytoplasmic surface.
(b) The digestion patterns of the human and pig
transporters show a single H-degradation peak at low
enzyme concentration, but a second peak of lower
molecular weight appears when the enzyme concentration is
increased 10-fold. Appearance of this peak is associated
with a concommitant decrease in the first peak. Thus,
there are at least two trypsin cleavage sites, one more
accessible than the other.
(c) The data presented in Table 5.1 and in Figs. 5.1
and 5.2 established that NBMPR and carbohydrate are
attached to the same half of the transporter polypeptide
in both species. This contrasts with the human
erythrocyte glucose transporter where the carbohydrate
and cytochalasin B attachment sites are located on
different halves of the transporter polypeptide (Cairns
etal., 1984 Deziel and Rothstein, 1984 see also Chapter
7, Section 7.4).
(d) From Table 5.1 it can be seen that the
difference in apparent molecular weight between.. the
deglycosylated human and pig nucleoside transporters is
13,000 before trypsin digestion but. only 7,000 for the
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deglycosylated tryptic 3H-fragments. This result excludes
the possibility that the species difference in apparent
molecular weight of the deglycosylated transporters
results from an 'extra' polypeptide segment at either the
N- or C-terminals of the pig transporter polypeptide.
If the Mr difference between the deglycosylated
human and pig transport proteins had been due to an
'extra' segment of polypeptide at the terminal end of the
region bering the NBMPR site and the carbohydrate
residue, then the original difference in apparent
molecular weight between the human and pig transporters
would have been retained in the tryptiv fragments. On the
other hand, if the extra segment of polypeptide was
present at the other terminal, then it would be expected
that the radiolabelled tryptic fragments from the two
species would have the same molecular weight after
endoglycosidase F digestion. Instead, it is likely that
the difference between the two transporters resides in
the middle region of the polypeptide, possibly in the
form of a loop. It is envisaged that the first trypsin
cleavage site is located within this loop (see General
Discussion). These results cannot, of course, exclude the
possibility that the pig transporter has additional
segents at both the N- and C-terminals. Interpretation of
the data also relies on the assumption that endo-
glycosidase F is efective in removing all carbohydrate
from the two transporters and that SDS-polyacrylamide gel
electrophoresis accurately reflects. molecular weight
97
differences between the intact and cleaved transporters
in the two species.
The digestion experiments with chymotrypsin show
that (a) there are chymotrypsin cleavage sites on both
sides of the membrane, and (b) that the extracellular
domains of the transporters have tighter structures under
isotonic conditions than under hypotonic conditions. The
former condition approximates more closely to the
situation in functioning erythrocytes. Digestion with
thermolysin shows only cleavage sites on the
extracellular domain of the transporters, with the pig
transporter being more succeptible to thermolysin
digestion.
It is perhaps not co-incidental that trypsin,
chymotrypsin and thermolysin all generate fragments in
the apparent molecular weight region between 31,000-
21,000 when high enzyme concentrations were used. This
might represent a part of the transporter in the lipid
bilayer, making additional enzyme cleavage sites
inaccessible. This region of the transporter contains the
carbohydrate and [3H]NBMPR attachment sites.
Treatment of membranes with amino peptidases and
carboxypeptidases failed to induce a significant
molecular weight shift of the [3H]NBMPR-labelling pattern
in either species. This suggests that the terminals of
the NBMPR binding protein are blocked or not exposed to
either side of the membrane or that the exposed segments
are so small that their digestion causes no detectable
98
shift in apparent molecular weight (ie <1000). These
experiments provide additional indirect evidence against
the presence of an additional N- or C-terminal 'tail' on
the pig transporter.
The transmembrane topology of the human and pig
erythrocyte nucleoside transporters is discussed in more
detail in Chapter 7, where models for the two
transporters are proposed. Chapter 7 also compares the
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The ion-exchange chromatography procedure described
in Chapter 3 produced a 140-fold purification of the pig
erythrocyte nucleoside transporter as judged by a
covalent radioactive NBMPR binding assay. This represents
a considerable improvement over the 13-fold purification
of the human erythrocyte nucleoside transporter achieved
by Jarvis and Young (1981). However, the partially-
purified pig nucleoside transporter preparation was not
homogenous (see Chapter 3 and 4). The present Chapter
presents preliminary experiments aimed at purifying the
human and pig erythrocyte nucleoside transporters by a
different technique, that of immunoaffinity
chromatography.
The attempted purification of the human protein
involved linking monoclonal antibodies directed against
the human erythrocyte glucose transporter to an affinity
support (Bio-Rad Affi-Gel 10). This served as an
immunoaffinity column onto which purified band 4.5
proteins (Jarvis and Young, 1981 Baldwin etal., 1982
Chapter 4) were applied. It was anticipated that the
glucose transporter (90% of the protein applied) would
bind to the column leaving the nucleoside transport
protein and other uncharacterised band 4.5 proteins in
the column void-volume fractions. In this way it was
hoped to achieve the physical separation of the human
glucose and nucleoside transport proteins, leading to a
significant enrichment of the latter.
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With respect to the pig system, the immunoaffinity
column contained monoclonal antibodies directed against
partially purified pig band 4.5 polypeptides (Good
et al., 1986). Pig erythrocyte membrane extract was then
applied to the column. In this case it was anticipated
that nucleoside transport polypeptides would be
selectively adsorbed onto the column. Subsequent elution
of the column, therefore, would be expected to generate a
membrane fraction enriched in transport protein.
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6.2 Methods
6.2.1 Cell and membrane preparation
Out-dated human blood was obtained from the Blood
Bank, Royal Free Hospital School of Medicine, London,
England. Fresh pig blood was obtained from Gainers Inc.,
Edmonton, Alberta, Canada. Erythrocyte membranes were
prepared for octyl glucoside solubilisation as described
in the Methods section of Chapter 3.
6.2.2 Monoclonal antibody preparation
6.2..2a Monoclonal antibodies against the human
erythrocyte glucose transporter
Monoclonal antibodies (GTRP-1) (Boyle etal., 1985)
were supplied by the Paterson Laboratories, Christie
Hospital, Manchester, U.K. Immunoglobulin was purified
from ascitic fluid (from mice implanted with hybridoma
GTRP-1) by precipitation with saturated ammonium
sulphate, added dropwise to slowly stirring ascitic fluid
at 4°C until the final concentration was 50% (w/v). Care
was taken to avoid frothing and the mixture was left in
the cold room overnight to ensure complete precipitation.
The precipitated protein was recovered by centrifugation
at 3000g for 30min at 4°C. %The pellet was dissolved in
the minimum volume of phosphate buffered saline (PBS) and
dialysed for 36 h against three 2-1 changes of HEPES
buffer (100mM, pH 7.5). The antibody' preparation was
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analysed by SDS-polyacrylamide gel electrophoresis and
was typically 85% immunoglobulin.
6.2.2b Monoclonal antibodies against the pig
erythrocyte nucleoside transporter
The partially purified pig erythrocyte band 4.5
extract prepared in Chapter 3 was used as immunogen by
Good, etal. (1986) in the development of monoclonal
antibodies against the NBMPR binding protein. Monoclonal
antibody production and purification were conducted at
the McEachern Laboratory, University of Alberta, Canada.
The 3E3 monoclonal antibody preparation used in this
study was purified on a Bio-Rad hydroxyapatite column and
the product was 80% immunoglobulin.
6.2.3 Coupling of monoclonal antibodies to affinity
support
Affinity support (Affi-Gel 10, N-hydroxysuccinimide)
was' purchased from Bio-Rad, Richmond, Ca, U.S.A. The gel
was washed with three bed volumes of cold (4'C) deionised
water using a Buchner funnel, care being taken not to
allow the gel to run dry. The washing was completed
within 20 min to allow optimum coupling of ligands. The
washed gel was then transferred into a conical flask and
the ice-cold monoclonal antibody solution (in HEPES 100
mM, CaCl 80 mM, pH 7.5) added slowly. The monoclonal
antibody concentration was 30 mg protein/ml gel in a
total reaction volume of 4.5 ml. The mixture was left to
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react for 4 hours at 4°C with gentle shaking. The
antibody-gel linking reaction was terminated by addition
of ethanolamine (0.1 M final concentration, pH 8.0) after
which the mixture was left to stand for one more hour.
After packing the gel in a small column, unbound ligand
and ethanolamine were removed by washing the gel with
three column volume of HEPES, or until the washings were
free of protein as detected by absorbance measurements at
280 nm.
6.2.4 Human erythrocyte nucleoside transporter
purification
6.2.4a Purification procedure
The partially purified human band 4.5 preparation
described by Baldwin, et al., (1982) and in Chapter 3
Section 3.2.2 was used as the starting material for the
immunoaffinity separation. The band 4.5 prepration was
solubilised at 4°C in buffer containing 50mM sodium
phosphate (pH 7.4), 100 mM NaCl, 1 mM EDTA and 34 mM
octyl glucoside. After washing the immunoaffinity column
with the same buffer, the solubilised band 4.5
preparation was passed through the column five times at a
flow rate of four column volumes per hour. The column-
treated solution was made 2mM in DTT before removal of
detergent by dialysis against four changes, each 2 1, of
detergent-free buffer over a period of 48 h.
Bound glucose transport proteins were removed from
the column by washing with four column' volumes of 50 mM
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diethylamine pH 11.0, 0.5% (w/v) deoxycholate. The
regenerated column was stored at 4°C in 50 mM Tris-HC1,
pH 7.4 containing 0.2% (w/v) sodium azide.
Anglysis of GTRP0-1 immunoaffinitu column6.2.4b
extract
Assays for reversible binding of NBMPR, photo-
affinity labelling with[ 3H]NBMPR, and SDS-polyacrylamide
gel electrophoresis were carried out as described in
Chapter 3, Section 3.2.2b, Chapter 4, Section 4.2.3b and
Chapter 2, Section 2.2.2d, respectively. Assays of
reversible cytochalasin-B binding were performed by
equilibrium dialysis as described by Baldwin et al.
(1982). Briefly, samples containing membrane proteins (40
ul) were added to one side of the dialysis membrane
(molecular weight cut-off 12,000-14,000daltons) and 40 ul
portions of [3 H]cytochalasin B (80 uM) in identical
medium (100 mM NaCl, 50 mM sodium phosphate, 1 mM EDTA,
pH 7.4) was added to the other well. Control wells
contained heat-inactivated samples and 500 mM D-glucose
to correct for nonspecific binding.
Photoaffinity labelling with[ 3H]cytochalasin B was
carried out as described in Chapter 4, Section 4.2.3b and
by Cairns etal., (1985). Void volume solutions obtained
when passing crude membrane extracts through DEAE
cellulose column, or solubilised band 4.5 fractions
through GTRP-1 immunoaffinity column, were incubated for
30min at 4°C with a saturating concentration of
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[ 3H]cytochalasin B (1 uM). Photolysis conditions were the
same as for [ 3H]NBMPR photolabelling (see Chapter 2,
Section 2.2.2b). Membrane material was recovered by
centrifugation at 130,0008 for lh, the pellets were
dissolved in SDS-gel buffer and electrophoresed on a 12%
S DS -polyacrylamide gel (see Chapter 2, Section 2.2.2d).
6.2.5 Pig erythrocyte nucleoside transporte purification
6.2.5a Purification procedure
[ 3H]NBMPR photolabelled, protein-depleted
erythrocyte membranes were solubilised as described in
Section 3.2.4 except that DTT was not included in the
solubilisation buffer and Triton X-100 (1% (w/v) final
concentration) was substituted for octyl glucoside. The
130,0002 Triton X-100 supernatant was made 0.12 M in NaCl
before passing through a DEAE-cellulose column
equilibrated with 5 mM Tris-HC1 (pH 7.4 at 4°C), 0.12 M
NaCl and 1% Triton X-100 (see Chapter 3, Section 3.2.4
for details of the chromatography procedure). Void-volume
fractions from the DEAE-cellulose column were then
applied to the 3E3 immunoaffinity column at a flow rate
of 2.5 column volume per h, and the column washed with 10
column volumes of the same buffer. Bound nucleoside
transporter was released by an elution buffer containing
50mM diethylamine (pH 11.0), 0.5% (w/v) deoxycholate.
Fractions containind radioactivity were pooled and
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dialysed free of diethylamine and deoxycholate against
two changes each of 2 1 of 50 mM sodium phosphate (pH
7.4), 100 mM NaCl, 1 mM EDTA for 24 h.
6.2.5b Analysis of immunoaffinity purified
preparation
The diethylamine/deoxycholate extract was
concentrated using an Amicon Centricon Concentrator and
analysed by SDS-polyacrylamide gel electrophoresis.
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6.3 Results
6.3.1 Human nucleoside transporter purification
6.3.1a Monoclonal antibody purification
The ascitic fluid supplied by the Paterson
Laboratory contained GTRP-1 monoclonal antibodies
specific for the human erythrocyte glucose transporter
(Boyle et al., 1986). Isolation of immunoglobulin from
the ascitic fluid was achieved by a one-step ammonium
sulphate precipitation procedure (Golding, 1983). The
degree of purification achieved was assessed by
SDS-polyacrylamide gel electrophoresis (Fig. 6.1). Before
ammonium sulphate precipitation, the ascitic fluid was
heavily contaminated with albumin (molecular weight
67,000) (Fig. 6.1, lane 1). After precipitation, two
major Coomassie Blue-stained bands were obtained with Mr
values of 55,000 and 27,000, representing the heavy and
light chains of IgG, respectively (Fig. 6.1, lane 2).
This procedure removed most of the albumin present in the
ascitic fluid. The minor protein bands in the high
molecular weight region of the gel may represent other
proteins present in the ascitic fluid or aggregrates of
immunoglobulins, or both. This preparation, in which
immunoglubulin comprised over 85% of the protein content,
was used for coupling to the Affi-Gel affinity support.








The purity of ammonium sulphate-precipitated monoclonal
antibodies (lane 2, 20ug protein) from ascitic fluid
(lane 1, 100ug protein) was monitered by SDS-polyacryl-
amide gel (10$) electrophoresis and staining with
Coomassie Blue as described in Section 6.2.2a. a and b
represent positions of the stacking gel-running gel









Table 6.1 Monitoring of monoclonal antibody coupling to
Affi-gel column and subsequent clearance of reactants.
Monoclonal antibodies (72 mg protein, 85% pure) were
mixed with the Affi-gel 10 resin as described in Section
6.2.3a. A total of 14.0 mg of protein was recovered from
the 3 washes, indicating that 49.0 mg of pure monoclonal
antibodied were linked to the column (see Section 6.3.1b
for details).
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6.3.1b Coupling of monoclonal antibodies to affinity
support
Table 6.1 presents data monitoring the coupling of
monoclonal antibody GTRP-1 to Affi-Gel 10 and subsequent
clearance of reactants. Of the 72 mg of ammonium
sulphate-purified antibodies added to the gel, 14 mg was
recovered after coupling. Taking into consideration that
only 85% of the starting material was IgG (Fig. 6.1), it
is estimated that 49.3mg of immunoglobin were linked to
the gel (8 ml), a coupling efficiency of 80%. Table 6.1
also shows that four washes (one column volume per wash)
was sufficient to remove the unbound proteins.
6.3.1c Purification studies
Table 6.2 summarises the NBMPR and cytochalasin B
binding activities of erythrocyte membranes and membrane
extracts during the initial DEAE-cellulose and subsequent
immunoaffinity separations. A non-saturating cytochalasin
B concentration was employed to assay cytochalasin B
binding activity. These data are, therefore, presented as
bound/free ratios.
The initial ion-exchange chromatography step
produced the expected 10-fold enrichment of the NBMPR-
binding component, although the starting specific
activity of NBMPR-binding to the erythrocyte ghosts was
low compared to the results obtained in Chapter 3,
Section 3.3.3 (10 pmol/mg protein cf 36 pmol/mg protein).
This probably reflects donor variability (Plagemann and
Total 1 igand bound Ligand-bindingTotal protein Specific ligand-
NBMPR C-B(ME) activity recovered binding activity
NBMPR C-B(B-TY)pmol) NBMPR C-B
(pmol mg) (B/FTm-g)
'Ghosts'
131.437.3 100100530 14.2 3.5
Protein-depleted 16.0 482 93.2 91 71 30.1 5.8
membranes
Octyl glucoside extract 625.0 65.2 18.6326 93.0 71
DEAE-cellulose extract 0.72 100 18.9 139.042.2 32 58.3
(void-volume)
1082.0 11.10.60.79 14.50.071GTRP-1-Affi-gel extract 76.8
(void-volume)
Table 6.2. Purification of the NBMPR-binding component from human erythrocyte membranes by immuno-
affinity chromatography. Solubilisation and chromatography procedures are detailed in Section
6.2.4a. NBMPR-binding and cytochalasin-B (C-B) binding assays were performed at a saturating (50nM)
and a non-saturating (80nM) concentration of ligand, respectively. B/F refers to the ratio of
bound/free cytochalasin-B. Values are the average of two separate experiments.
% %
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Wohlhueter, 1984c) and may also be related to the use of
out-dated human blood in this series of experiments.
Differences in NBMPR-binding and nucleoside transport
kinetics have been reported between fresh and out-dated
blood (Jarvis etal., 1983 Plagemann and Wohlhueter,
1984c).
Passage of the DEAE-cellulose column void-volume
extract through the GTRP-1 immunoaffinity column resulted
in the adsorption of most of the applied protein, only
10% being recovered in the void-volume of the
immunoafinity column. However, 77% of the added NBMPR
binding-activity was associated with this fraction. This
step increased the specific activity of NBMPR-binding by
a factor of 8 to 1082 pmol/mg protein (Table 6.2),
representing an overall 76-fold purification of the
NBMPR-binding component. In contrast, the GTRP-1 column
removed 98% of the starting cytochalasin B-binding
activity.
6.3.1d Characterisation of the immunoadsorbant column
preparations
Exposure of the DEAE and the immunoaffinity column
void-volume extracts to UV light in the presence of
[ 3H]NBMPR and'[ 3H]cytochalasin B under equilibrium
binding conditions resulted, in covalent incorporation of
radioactivity into band 4.5 proteins present in the
extracts. As shown in Figs. 6.2 and 6.3 SDS
polyacrylamide gel electrophoretograms of both extracts
Fig.6.2 Photoaffinity labelling of human erythrocyte
membrane extracts with[ 3H]NBMPR before and
after immunoaffinity chromatography.
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Membrane extracts (13ug protein) before(•) and after
immunoaffinity column chromatography (0) were photo-
labelled with a saturating concentration of[ 3H]NBMPR as
described in Section 6.2.4b and electrophoresed on a 10%
SDS-polyacrylamide gel. (a, stacking gel-running.. gel




Fig. 6.3 Photoaffinity labelling of human erythrocyte
membrane extracts with[ -Hjcytochalasin B before
and after immunoaffinity column chromatography.











Membrane extracts (13ug protein) before(•) and after (0)
immunoaffinity column chromatography were equilibrated
with luM[ H]cytochalasin B for 30min followed by
exposure to UV light. Photolysis conditions and
SDS-polyacrylamide gel electrophoresis were identical to
those used in Fig.6.2. (a, stacking gel-running gel
















Fig.6.4 SDS-polyacrylamide gel electrophoresis of human








SDS-polyacrylamide gel electrophoresis was performed as
described in Fig.6.1. The amounts of protein in each lane
were 13ug. Lane 1, band 4.5 proteins after immunoaffinity
chromatography. Lane 2, band 4.5 proteins before
separation, a and b represent positions of the- stacking
gel-running gel interface and tracking dye, respectively.
66K, for example, 66,000.
Fig.6.5 Concentration dependence of NBMPR-binding to the






























The amount of[ H]NBMPR bound to the purified preparation
in the presence (O) and absence(•) of 10 uM NBTGR is
ploted against the equilibrium concentration of free
NBMPR. The inset shows a Scatchard plot of the data
(corrected for the NBTGR-insensitive component of
binding).
after photo-activation of the ligand exhibited peaks of
radiolabelling in the band 4.5 region of the gel which
co-migrated with the single broad band of Coomassie Blue
staining given by the preparations (apparent Mr (average)
55,000) (Fig. 6.4).
Human erythrocyte band 4.5 proteins before and after
GTRP-1 immunoaffinity (Fig. 6.4 lanes 1 and 2,
respectively) had similar Coomassie Blue staining
profiles, but exhibited different radiolabelling
3
patterns. The[ H]NBMPR-labelled DEAE-extract had a
specific activity of band 4.5 radiolabelling of 173.1
cpmug protein whereas the GTRP-1 immunoaffinity purified
material had a corresponding specific activity of 1383
cpmug protein, an increase of 8.0-fold. On the other
hand, the specific activity of cytochalasin-B
radiolabelling showed a decrease of 9.9-fold (1635 cpmug
vs 165.4 cpmug). The small amount of radioactivity
associated with the GTRP-1 imunoaffinity purified
preparation probably reflects non-specific labelling by
cytochalasin-B (Carter-su et al., 1983; Shanahan et al.,
1983).
These covalent labelling results therefore confirm
the reversible binding data presented in Table 6.1. The
apparent Kd value for reversible NBMPR binding to the
membrane protein after immunoaffinity purification was
2.0 nM (Fig. 6.5).
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6.3.2 Pig nucleoside transporter purification
The pig erythrocyte immunoaffinity purification
procedure differed from that described above in that the
nucleoside transporter was adsorbed onto the monoclonal
antibody-linked Affi-gel column. In these circumstances,
it is necessary to achieve optimal release of the antigen
from the column since this will influence the yield of
nucleoside transporter and possibly the extent of
purification achieved. Based on the conditions used tc
regenerate the GTRP-l column in Section 6.2.4a, a series
of experiments were preformed to establish optima]
conditions for antigen removal.
6.3.2a Pilot studies
A lml 3E3-Affi-gel column was loaded with 2m1 of the
NBMPR-radiolabelled Triton X-100 crude membrane extract
described previously (Section 6.2.5a) and the column was
washed with 20 ml of 1% (w/v) Triton X-100, 50 mM
Tris-HC1 pH 8.0, before resuspension of the gel in 2 ml
of the same buffer. Aliquots (0.25 ml) were added to
Eppendorf microcentrifuge tubes, different elution
buffers added, and the tubes rotated gently for 30' min at
room temperature. Samples were then centrifuged briefly
(5 s, 12,0008) and supernatants removed for radioactivity
determination. Table 6.3 shows the percentage of bound
antigen released by the different buffers. Buffer B (50
mM diethylamine, 0.5% (v/v) deoxycholate, pH 11.0) eluted
the most radioactivity (74.6%) from the affinity column.
Radioactivity elutedDeoxychola toDiethylaminiElution buffer pH










Table 6.3. Elution of bound radioactivity from 3E3-Affi-gel. A 1ml Affi-gel column was loaaea
with NBMPR-radiolabelled• pig crude Triton X-100 extract. After extensive washing with 1% Triton
X-100, 50mM Tris-HC1 (pH 8.0), the Affi-gel resin was removed to Eppendorf micro-centrifuge tubes
and treated with the above elution buffers (30min incubation at room temperature). H and I are
resin treated with the washing buffer with and without incubation, respectively. Initial
radioactivity per sample is 22490 cpm.
Cpm recoveredProtein recoverec
( % )( % )
100100Protein-depleted membranes






Table 6.4. Purification of the NBMPR-binding component from pig
erythrocyte membranes by immunoaffinity chromatography. Details
of the experimental procedures used are detailed in Section
6.2.5a. Data are the average of two separate experiments and
expressed as% protein and total radioactivity recovered with
respect to the starting protein-depleted membranes.
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This condition is identical to that used to elute the
glucose transporter from the GTRP-1-Affi-gel column (see
Section 6.2.4a).
6.3.2b Purification procedure
Preliminary experiments established that direct
application of the 130, 0002 crude Triton X-100 membrane
extract to the 3E3-Affi-gel column led to significant
non-specific adsorption or trapping of solubilised
protein in the column matrix. Therefore, elution of the
column with buffer B released proteins other than band
4.5 polypeptides (data not shown). Therefore, to reduce
non-specific adsorption, the Triton X-100 crude extract
was made 0.12 M in NaCl (see Chapter 3, Section 3.3.5)
and applied to a DEAE-cellulose column pre-equilibrated
with the same buffer prior to immunoaffinity
chromatography. Table 6.4 shows values for the protein
content' of the preparation during the various stages of
the purification. Triton X-100 solubilised 55% of the
membrane protein and 74% of the membrane- associated
radioactivity, values similar to those obtained with
octyl glucoside (see Chapter 3, Section 3.3.3). The
DEAE-cellulose column equilibrated with 0.12 M NaCl
removed 69% of protein in the crude extract and 40% of
the radioactivity. The final diethylamine/deoxycholate
preparation contained 0.14% of the starting protein, but
11% of the membrane-associated radioactivity present in
the original protein-depleted membranes.
Fig.6.6 SDS-polyacrylamide gel electrophoresis of 3H-
labelled pig erythrocyte NBMPR-binding protein
before and after purification by immunoaffinity
chromatography
Protein-depleted membranes were photolabelled with (,3H]
NBMPR, solubilised in octyl glucoside and subjected to
ion-exchange and immunoaffinity column chromatography as
detailed in Section 6.2.5a. Fractions containing radio-
activity released by diethylamine/deoxycholate were
pooled, dialysed and concentrated by an Amicon centricon
concentrator. Samples of this purified extract (2.4ug
protein, B) and the starting protein-depleted membranes
(90ug protein, A) were analysed by SDS-polyacrylamide gel
electrophoresis as described in Chapter 2, Section
2.2.2d. Lane C represents a densitometric scan of the
Coomassie Blue-stained purified extract. 3H-profiles and
the positions of molecular weight standards are from the
same slab gel. The positions of the stacking gel-running
gel interface and the tracking dye are indicated by a and
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As shown in Fig 6.6 (lane C), only 2 Coomassie Blue
stained bands were detected in the diethlyamine/deoxy-
cholate extract, one relatively sharp band with an
apparent molecular weight of 70,000 and the other broader
band with an apparent molecular weight of 64,000. The
64,000 Coomassie Blue-stained band co-migrated with the
major radioactive peak given by the same preparation
(Fig. 6.6). Fig. 6.6 also directly compares the H-gel
profile of the concentrated diethylamine/deoxycholate
extract with that of the radiolabelled protein-depleted
membranes from which it was derived. Specific activities
for protein-bound 3H were 201 cpm/ug protein for the
protein depleted membranes and 8651 cpm/ug protein for
the diethlyamine/deoxycholate extract. Thus, solubili-
sation of protein-depleted membranes and subsequent
ion-exchange and immunoaffinity chromatography resulted
in a 43-fold purification of radiolabelled NBMR-binding
protein. The average purification achieved in 2 separate
experiments was 41-fold. Since the initial removal of
extrinsic membrane proteins from pig erythrocyte ghosts
results in a 2.3-fold increase in specific activity of
NBMPR-binding (see Chapter 3, Section 3.3.4), the overall
purification achieved was 94-fold. This corresponds to a
purification of *285-fold with respect to the 64,000
Coomassie-Blue band, this region of the gel contributing
33% of the protein present in the diethylamine/deoxy-
cholate extract (Fig. 6.6). It should be noted that the
final preparation did not contain the low molecular
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weight contaminant (Mr 43,000) seen with the
DEAE-cellulose ion-exchange chromatography procedure (see
Chapter 3, Section 3.3.4).
6.4 Discussion
The two immunoaffinity purification procedures
described in this Chapter shown promising results,
producing 76- and 94-fold purification of the human and
pig nucleoside transport proteins, respectively.
The human nucleoside transporter present in the
DEAE-cellulose isolate was further purified 8-fold by one
step immunoaffinity column chromatography. The GTRP-1
affinity column selectively removed glucose transport
protein from the initial partially purified preparation.
However, maximum purification was not achieved for the
following possible reasons. (1) The exact composition of
the DEAE-cellulose void-volume extract is not known.
Apart from the glucose and nucleoside transporters the
preparation may also contain other transport proteins.
Thus, the lactate transporter has been shown to be a
band 4.5 polypeptides (Jennings and Adams-Lackey, 1982).
Erythrocyte amino acid transporters may also be band 4.5
proteins (Ellory et al., 1985; Fincham et al., 1985). (2)
The relatively large glucose to nucleoside transporter
ratio (20:1) in the DEAE-cellulose membrane extract
(Jarvis and Young, 1981 Baldwin et al., 1982) means that
the Affi-gel column must have a sufficiently large
capacity to ensure complete adsorption of glucose
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transporter. Even slight over-loading of the column could
lead to significant contamination of the nucleoside
transporter fraction. (3) Glucose transport proteins
damaged during the course of isolation might not bind to
the antibody and co-elute with the nucleoside transporter
in the GTRP-1 affinity column void-volume. (4) Since DTT
was not included in the solubilisation buffer (to avoid
reduction of antibody disulphide bridges), there was an
increased possibility of nucleoside transporter
inactivation and hence a loss of NBMPR-binding activity
(see Table 5.2). This would underestimate the degree of
purification obtained. (5) Finally, as mentioned earlier,
the initial specific activity of reversible NBMPR-binding
to the starting protein-depleted membranes was low.
Nevertheless, the experiments described here provide a
clear demonstration of the feasibility of purifying the
human erythrocyte nucleoside transporter by
immunoaffinity chromatography. The results also represent
the first successful attempt to chromatographically
separate the human erythrocyte glucose and nucleoside
transporter polypeptides.
Immunoaffinity chromatography achieved a 94-fold
purification of the pig nucleoside transporter (or
285-fold with respect to the 64,000 dalton band present
in the preparation). These figures are less than those
obtained by the gradient-elution ion-exchange method (see
Chapter 3). However, the lower molecular weight band (Mr
45,000) present in the DEAE-cellulose gradient extract
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was not present in this preparation. The identity of the
70,000 dalton impurity present in the immunoaffinity
purified preparation is not known, but one possibility is
that it is derived from ascitic fluid proteins other than
MAb 3E3 that become linked to the Affi-Gel 10 matrix (ems.
albumin) (see Section 6.2.2b).
Although the 3E3 immunoaffinity purification of the
NBMPR binding protein from pig erythrocytes did not show
any improvement in purification over the DEAE cellulose
chromatographic method, the simplicity and speed of this
procedure recommend it for further investigation.
Clearly, both the human and pig immunoaffinity procedures
require further modification and refinement in order to
optimise the degree of purification which can be achieved
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The preceding Chapters describe photoaffinity
labelling, isolation and molecular studies of the human
and pig erythrocyte nucleoside transporters. This Chapter
attempts to draw these investigations together and also
presents a discussion of the molecular similarities and
differences between the human nucleoside and sugar
transport systems and the human and pig erythrocyte
nucleoside transporters. Some of the ways in which the
studies described in this Thesis might usefully be
extended are also indicated.
7.2 identification of nucleoside transport proteins
The technique of photoaffinity labelling with[ 3 H]
NBMPR was found to be indispensable for the isolation and
molecular studies described in this Thesis. Although the
nucleoside transporter only accounts for 0.3-0.6% of the
membrane protein in human or pig erythrocytes (much less
in other species), exposure of human and pig erythrocyte
membranes to UV light in the presence of [3H]NBMPR
results in selective incorporation of radioactivity into
band 4.5 polypeptides that migrate as a broad band on
SDS-polyacrylamide gels (apparent molecular weight
45,000-66,000) (see Chapter 2, Sections 2.3.1 2.3.4). A
variety of experimental approaches were used to establish
that [3H]NBMPR specifically radiolabelled nucleoside
transporter polypeptides. This radioactive tag', was
subsequently used to facilitate detection of the NBMPR
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binding protein during isolation and molecular studies
(see Chapters 3, 4, 5 and 6). The technique of
photoaffinity labelling with [3H]NBMPR has since been
exploited widely to probe the identity and properties of
nucleoside transport proteins in a variety of cell types
and tissues.
For example, exposure of membranes from cultured
mouse S49 lymphoma cells, rat and guinea pig liver and
lung, and guinea pig cardiac muscle and brain to UV light.
in the presence of [3H]NBMPR has been demonstrated to
result in the covalent radiolabelling of membrane
protein(s) which migrate on SDS-polyacrylamide gels with
an apparent molecular weight of 66,000-45,000 (Almeida
et al., 1984 Young et al., 1984 Wu and Young, 1984; Shi
et al., 1984 Kwan and Jarvis, 1984 Jarvis and Ng,
1985). Membrane proteins from AE1 cells' a nucleoside
transport- deficient clone isolated from a mutagenised
population of S49 cells (Cohen et al., 1979; Cass et al.,
1981) are not covalently labelled by [3 H]NBMPR (Almeida
et al., 1984; Young et al., 1984). These results strongly
suggest that NBMPR-sensitive nucleoside tansport activity
in different tissues and cells is' catalysed. by proteins
with similar molecular properties. One apparent
difference between rat and guinea pig tissues (lung,
liver) is the finding that the Mr of the major radio-
active peak in rat tissues is always higher than the
corresponding radioactive guinea pig peak (approx. 60,000
compared to 55,000) (Wu and Young, 1984); Shi etal.,
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1984). Recent studies with rat erythrocytes also
demonstrate that the rat radioactive peak in the band 4.5
region has a higher apparent molecular weight than that
of the human erythrocyte transporter (Jarvis and Young,
1986). The origin of this molecular weight difference is
discussed in Chapter 4, Section 4.4.
In some lines of cells,- e.g. in cells of the
uncloned Novikoff hepatoma and Walker 256 carcinosacroma
lines, equilibrative nucleoside transport is of low
sensitive to NBMPR (Plagemann and Wohlhueter 1984
Paterson et al., 1983 Belt and Noel, 1985). Consistent
with this observation is the' finding that these cells
also lack high-affinity sites for NBMPR (Paterson et al.,
1983 Plagemann and Wohlhueter 1984a), although such
sites are present on cells of another uncloned Novikoff
hepatoma line (Novikoff-UA cells) where nucleoside
transport is also not inhibited by nanomolar
concentrations of NBMPR (Gati et al., 1986a). The
apparent Mr of these NBMPR binding sites on Novikoff-UA
cells as revealed by photoaffinity labelling studies with
[ 3 H]NBMPR is significantly higher (80,000-72,000) than
that reported for corresponding -polypeptides in other
cell types and tissues (Gati etal., 1986a). The inability
of NBMPR to inhibit nucleoside transport in this Novikoff
variant is in dispute (Plagemann and Wohlhueter, 1985).
Thus, the relationship of the NBMPR binding- sites on
Novikoff-UA cells with the nucleoside transport mechanism
is unclear.
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In addition to its use as a means of exploring the
structure of the NBMPR-sensitive nucleoside transporter,
[ 3H]NBMPR photolabelling has also been exploited in
screening tests to identify hybridoma clones that produce
monoclonal antibodies directed against the NBMPR binding
protein (Jarvis et al., 1985b Good et al., 1986).
7.3 Lipid requirement of the erythrocyte nucleoside
transporter
DEAE-cellulose chromatography of solubilised pig
erythrocyte membranes generated a lipid depleted
nucleosde transporter fraction (Chapter 3). Most of the
phospholipids were eluted in the column void-volume
(75%), whereas the transporter- containing fractions
contained only 10% of the solubilised lipid. The loss of
lipid caused a 5.lfold increase in.. the apparent
dissociation constant for high affinity binding of NBMPR
to the partially-purified transporter (from 1.4 nM for
the starting membranes and solubilised membrane extract
to 7.2 nM for the purified preparation). Adjustment of
the chromatography conditions so that the transporter
eluted in the column void volume along with the majority
of the solubilised lipid reduced the apparent Kd to 3.0
nM. A similar situation was reported for the partially
purified human erythrocyte nucleoside transporter (Jarvis
and Young, 1981), the nucleoside transporter recovered in
the column void-volume fraction having a significantly
higher apparent Kd (2.4 nM) than that of the membrane
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ghosts (1 nM). Examination of the crude Triton extract
showed a Kd identical to that of the membrane ghosts.
These observations suggest that lipid interactions with
the transporter are important for the normal expression
of NBMPR binding activity, a conclusion supported by the
finding that non-ionic detergents inhibit ligand binding
to the transporter. These effects are presumably mediated
through conformational changes of the transporter
polypeptide(s) (Jarvis and Young, 1983 Tse etal., 1985).
it has recently been established that nucleoside
transport activity in reconstituted liposomes is strongly
dependent upon the phospholipid composition of the
vesicles( C.M. Tse, personal communication).
7.4 Molecular properties of erythrocyte nucleoside and
glucose transport proteins
Nucleoside and glucose transport in human erythro-
cytes involves band 4.5 polypeptides, and D-glucose
sensitive cytochalasin B-binding activity co-purifies
with high-affinity NBMPR-binding activity during Triton
X-100 and octyl glucoside extraction of membranes and
subsequent ion-exchange chromatography (Jarvis and Young,
1981 see also Chapters 3 and 4). There is, however,
considerable evidence to indicate that cytochalasin B-
sensitive glucose transport and NBMPR-sensitive
nucleoside transport are catalysed by separate carrier
systems. Covalent attabhment of[ 3i]NBMPR to band 4.5 is
blocked by nucleosides, NBTGR and dipyridamole (Chapter
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2, Table 2.1), but not by cytochalasin B or D-glucose (Wu
et al., 1984). Also, [3 H]NBMPR selectively labels band
4.5 polypeptides in membranes from pig erythrocytes
(Chapter 2, Section 2.3.4 Chapter 3, Section 3.3.3
Chapter 4, Section 4.3.1 Young et al., 1985), cells
which transport nucleosides rapidly but lack a functional
glucose transporter (Kim and. McManus, 1971, Jarvis
et al., 1980a, Young et al., 1985). In contrast, no
detectable site specific labelling occurs in membranes
prepared from nucleoside-transport deficient sheep
erythrocytes (Chapter 2, Section 2.3.4).
The human erythrocyte glucose transporter can be
covalently labelled with[ 3H]cytochalasin B,an inhibition
of hexose transport (Chapter 4, Section 4.3.1 Baldwin
et al., 1980, 1981, 1982 Kasahara and Hinkle, 1977
Shanahan, 1982 Carter-Su, et al., 1982 Allard and
Lienhard, 1985). The attachment of[ 3 H] cytochalasin B
to band 4.5 is inhibited when the reaction is performed
in the presence of 600 mM D-glucose (Carter-Su et al.,
1982) but not in the presence of the nucleoside transport
inhibitors, NBMPR and NBTGR (Wu et al., 1984). In
addition, no photolabelling of pig erythrocyte membrane
by [3 H]cytochalasin B is observed (see Chapter 3). These
findings provide, strong evidence that erythrocyte sugar
and nucleoside transport are mediated by separate
proteins. Nevertheless, band 4.5 polypeptides radio-
labelled with[ 3 H]NBMPR or [3 H]cytochalasin B co-migrate
on SDS -polyacrylamide gels with indistinguishable
apparent molecular weights (Chapter 4, Section 4.3-1).
125
Further evidence of molecular similarities between
the human erythrocyte nucleoside and glucose transporters
comes from a photoaffinity labelling study with a
nucleoside permeant, 8-azidoadenosine (Jarvis et al.,
1986). The intention of that investigation was to
develope photoaffinity analogues of transported
nucleosides that would interact with the permeant binding
site on human erythrocyte. Photoactivation of
[3 H]8-Azidoadenosine in the presence of DTT, resulted in
selective incorporation of radioactivity into band 4.5
polypeptides of human erythrocyte membranes (Jarvis
et al., 1986). Covalent labelling was blocked by
nucleosides but not affected by the adenosine receptor
ligands, cyclohexyladenosine and L-n-phenylisopropyl-
adenosine, nor by the adenosine deaminase inhibitor,
2'-deoxycoformycin. These results would be consistent
with the photolabelling by[ 3H]8-azidoadenosine of human
erythro- cyte band 4.5 polypeptides involved in
nucleoside permeation. However, such a conclusion would
be inconsistent with the following observations: (a)
NBMPR, NBTGR and dilazep had no effect on photolabelling,
(b) covalent attachment of[ 3 H]8-azidoadenosine was
blocked by D-glucose and cytochalasin B, and L-glucose
and cytochalasin. E had no such effect. (c) No detectable
covalent labelling occured in membranes from rabbit and
pig erythrocytes, cells that transport nucleosides
rapidly, but have little or no functional glucose carrier
activity. (d) Trypsin digestion of unsealed human
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erythrocyte membranes photolabelled with[ H]8-azicio
adenosine yeilded a single radioactive fragment of Mr
19,000, a pattern identical to that obtained with
[ 3H]cytochalasin B-labelled membranes (Cairns et al.,
1984 Klip et al., 1984 Diezel and Rothstein, 1984
Janmohamed et al., 1985 Jarvis et al., 1986). The data
therefore suggest that, despite. 8-azidoadenosine being a
permeant for the nucleoside transporter, under
photoactivation 8-azidoadenosine perferentially labeled
the glucose carrier.
7.4.1 The human nucleoside and glucose transporters are
glycoproteins
The broadness of the [3 H]NBMPR-labelled human band
4.5 (Mr= 66,000-45,000) suggests that these poly-
peptide(s), like the glucose transporter (Gorga et al.,
1979 Cairns et al., 1984 Lienhard et al., 1984), are
extensively glycosylated. Chapter 4 examined in detail
the effects of endo-4B-galactosidase and endoglycosidase F
digestion on the Coomassie Blue-stained polypeptide(s) of
band 4.5, as well as the H]NBMPR and[ 3 H]cytochalasin
B-labelling profiles. Endo- -galactosidase digestion
partially deglycosylated the transporters and reduced the
apparent Mr (average) of the proteins from 56,000 to
47,000 and 48,000, respectively. Complete deglycosylation
was achieved by endoglycosidase F, with reduction in the
apparent Mr (average) to 44,000 and 45,000 for the
nucleoside and glucose transporters, respectively. In
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other words, the two polypeptides differ in molecular
weight by only 1000 daltons. Molecular similarities
between the 2 carrier proteins are also apparent during
DEAE-cellulose ion-exchange chromatography (Chapter 4,
Section 4.2. Jarvis and Young, 1981 Baldwin et al.,
1982).
7.4.2 Transmembrane topology of the human nucleoside and
glucose transporters
Exploration of the transmembrane topology of the
nucleoside and glucose transporters shows additional
evidence of molecular similarities between the two
carrier proteins. Current information on the trans-
membrane arrangement of the human glucose transporter
comes from two lines of evidence: (a) proteolytic
digestion studies (Cairns et al., 198.4 Deziel and
Rothstein, 1984 Shanahan and D'Artel-Ellis, 1984
Janmohamed et al., 1985),(b) and hydropathy plots of the
polypeptide amino acid sequence determined by gene
cloning experiments (Mueckler et al., (1985).
Fig. 7.1A summarises the positions of the trypsin
cleavage sites and carbohydrate and cytochalasin B
attachment sites of the human glucose transporter. This
schematic representation of the glucose transporter is
modified from information presented by Mueckler et- al.
1985, Cairns et al. 1984, Deziel and Rothstein 1984 and
Shanahan and D'Artel-Ellis 1984. The polypeptide is
believed to go traverse the membrane 1.2 times (Mueckler,
Fig. 7.1 Schematic representation of the transmembrane
arrangement of the human erythrocyte glucose (A)
and nucleoside (B) transporters and pig












carbohydrate moieties -CB, cytochalasin B labelling
site -NBMPR, NBMPR labelling site trypsin cleavage
site N, N-terminal c, C-terminal o, outside of
membrane.
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et al., 1985) but for the sake of simplicity only three
loops are shown in Fig. 7.1. The N- and C-terminals are
exposed to the cytoplasm, with the carbohydrate close to
the N-terminal on the outside of the membrane and the
cytochalasin B binding site located on the inside of the
membrane (Deziel and Rothstein, 1984 Janmohamed et al.,
1985). The exact location of the cytochalasin B
attachment site is not known, but Shanahan and D'Artel-
Ellis, (1984) and Cairns et al. (1984) have suggested
that the site is fairly close to the C-terminal end of
the polypeptide. An important feature of the model is the
presence of a large central cytoplasmic region which
contains two trypsin cleavage sites.
Trypsinisation of the[ 3 H]cytochalasin B-labelled
glucose transporter yields a non-glycosylated H-labelled
fragment of Mr 18,000 and a nonradioactive glycosylated
fragment of Mr 23,000-42,000 (Cairns et al., 1984). As
detailed in Chapter 5, trypsin treatment of the human
erythrocyte nucleoside transporter yields a glycosylated
[ 3H]NBMPR-labelled fragment of similar Mr. Apparent
differences in the cleavage patterns between the two
transporters evidently result from the different sites of
attachment of the two radiolabelled probes, the NBMPR
site being located on the outer surface of the
transporter relatively near the site of carbohydrate
attachment. Like the glucose transporter, the initial
trypsin cleavage site is located on a cytoplasmic domain
of the transporter, possibly within a hydrophilic loop.
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It seems likely that molecular similarities between
the human erythrocyte glucose and nucleoside transporters
is not co-incidental and that they might reflect some
degree of amino acid sequence homology, perhaps
indicating a common evolutionary origin. In this context
it should be noted that nucleosides can be regarded as
modified pentoses. It has recently been reported that
there is extensive structural homology between the human
glucose transporter and several bacterial H+ /pentose
transporters (Maiden etal., 1987). This structural
homology includes the common presence of a central
cytoplasmic loop. A simple molecular model of the human
erythrocyte nucleoside transporter based on that of the
glucose carrier is presented in Fig. 7.1B.
7.4.3 Transmembrane topology of the human and pig
nucleoside transporters
Photoaffinity labelling experiments described in
Chapter 2 have established that the pig erythrocyte
nucleoside transporter is a band 4.5 polypeptide, and
that its apparent molecular weight on SDS-polyacrylamide
gels is higher that than of the human transporter (Mr
(average) 64,000 c.f. 56,000). The isolation studies
presented in Chapter 3 show that the pig transporter also
behaves differently from the human transporter during
DEAE cellulose ion-exchange chromatography. The human and
pig erythrocyte nucleoside transporters are both
glycoproteins (Chapter 4) but their carbohydrate
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structures are different (endo- -galactosidase degrades
those of the former, but not of the latter, and
endoglycosidase F degrades both). The polypeptide
structures of the two transporters also differ, the
deglycosylated pig protein migrating on SDS-polyacryl-
amide gels with an apparent molecular weight of 57,000
compared with 44,000 for the deglycosylated human
transporter. However, the proteolytic digestion
experiments described in Chapter 5 suggest that the human
and pig nucleoside transporters have similarities with
respect to their arrangment in the erythrocyte membrane,
the loci of enzyme cleavage sites being in similar
domains. That is, trypsin cleavage occurs in cytoplasmic
domains of the human and pig nucleoside transporters,
chymotrypsin cleaves at cytoplasmic and external regions,
and thermolysin cleaves only the external regions of the
NBMPR binding protein. The proteolytic sensitivity of the
transporters differed with respect to the extent of
proteolysis and the size of the polypeptide fragments
generated after digestion. The trypsin and endoglycosid-
ase F digestion experiments presented in Chapter 5
provide evidence that the structural differences between
the two proteins are not due to an extra length of
polypeptide at either the N- or C-terminals, but rather
may reflect the presence of an additional polypeptide
sequence in the mid-region of the pig transporter
protein. A diagramatic representation of the postulated
differences between the human and pig nucleoside
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transporters is presented in Fig. 7.1, the pig protein
having a larger intracellular loop than the human
nucleoside transporter.
7.6 Future trends
The ion-exchange and pilot immunoaffinity
chromatographic studies described in Chapters 3 and 5
should serve as useful starting points for future
isolation and molecular studies. The immediate aim of
such studies would be the elucidation of the amino acid
sequences of the pig and human nucleoside transport
proteins. The following approaches could be employed:
(1) It is envisaged that the technique of photoaffinity
labelling will be widely used in subsequent
purification and molecular studies.
2) Purification of the human erythrocyte nucleoside
transporter by 'negative' immunoaffinity chromato-
graphy to remove glucose transporter protein, as
described in Chapter 5, could be scaled up to
produce adequate amounts of purified transporter for
monoclonal antibody production, N- and C- terminal
analysis and controlled proteolysis to generate
small fragments (including those radio- labelled- by
NBMPR) for amino acid sequence determination by fast
atom bombardment mass spectrometry and gas phase
sequencing.
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(3) The- transport (after reconstitution) and ligand-
binding characteristics of highly purified human
NBMPR binding protein should be compared with those
seen in the intact erythrocyte in order to determine
whether the transport system has been isolated in
its entirety and to ensure that there is no
contamination of the purified preparation by glucose
transporter. Such experiments will establish whether
NBMPR binds to the translocating polypeptide or to a
separate regulatory subunit. The develpoment of
substrate (permeant) analogue probes that bind
covalently at permeation sites in combination with
proteolytic digestion experiments would help resolve
whether NBMPR and nucleoside permeants bind to the
same or different sites on the transporter.
(4) When antibodies against the purified nucleoside
transport protein are raised, they can be used to
probe for cross-reactivity with human HepG2 protein
resolved by SDS gel electrophoresis on immunoblots
(Mueckler et al., 1985). Such immune reagents could
be used to screen a HepG2 complementary DNA (cDNA)
library in the expression vector gtll (Young and
Davis, 1983) for recombinant- phage that express
nucleoside transporter antigenic determinants. The
availability of partial amino acid sequences (see
(2)) would permit complementary gene cloning experi-
ments by construction of appropriate cDNA probes.
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(5) After elucidation of the amino acid sequence,
possible arrangements of the polypeptide in the
lipid bilayer could be deduced from appropriate
hydropathy plots (Mueckler et al., 1985). The
location of the NBMPR binding site would be
identified from the position of the amino acid
residue(s) covalently linked to[ 3 H]NBMPR.
Similarly, the availability of substrate level
probes would serve to identify the permeation site
of the transporter.
(6) Complementary experiments should serve to elucidate
the amino acid sequence of the pig erythrocyte
nucleoside transporter. Indeed, monoclonal
antibodies directed against this protein are already
available. We will then be in a position to identify
the molecular difference(s) between the human and
pig nucleoside transporters, and possibly to
identify those structural features essential for
permeant translocating.
(7) The nucleoside transporter, amino acid sequences
will, of course, also be compared closely with that
of the glucose transporter, establishing the extent
of structural homology between the two systems and
providing considerable additional information
concerning structure-function relationships. These
studies will also shed light on the molecular
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evolution of mammalian nucleoside and glucose
transport proteins.
(7) It is envisaged that such studies would be extended
to the study of NBMPR-insensitive and Na+-dependent.
nucleoside transporters, resolving the molecular and
evolutionary relationships between these different
functional classes of nucleoside transporter.
(8) The availabibity of monoclonal/polyclonal antibodies
against nucleoside transporter polypeptides will
also provide invaluable tools for the study of
important aspects of the cell biology of nucleoside
transport such as transporter regulation and
turnover.
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[G-3 H]NBMPR (specific radioactivity, 17-37 Ci/mmol
and 98% radiochemically pure) was purchased from Moravek
Biochemicals, Brea, CA. [2- 14 C]uridine (specific radio-
activity 53 mCi/mmol, 98% radiochemically pure), D-[U-
C]glucose (specific radioactivity 278 mCi/mmol, 98%
radiochemically pure), L-[1- 14 C]glucose (specific radio-
activity 58 mCi/mmol, 98% radiochemically pure),
3-0-methly-D-[U- 14 C]glucose (specific radioactivity 295
mCi/mmol, 98% radiochemically pure) and [4(n)- 3H]cyto-
chalasin B (specific radioactivity 17 Ci/mmol, 98%
radiochemically pure) were purchased from Amersham
International (Amersham, Bucks., U.K.).
A 1.2 Chemicals
NBTGR was a generous gift from Professor A.R.P.
Paterson, University of Alberta Cancer Research Group.
Dipyridamole (2,2 2,,''' - (4, 8- dipiperidinopyrimido[5,
4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol) (Persantin
injection) was obtained from Boehringer Inhelheim
Bracknell, Berks, U.K. Molecular weight standards for
SDS-polyacrylamide gel electrophoresis, ammonium per-
sulphate and T E M E D (N, N, N', N' -tetramethylethylenedi-
amine), acrylamide (99.9% pure) were from Bio-Rack, Brea,
CA, USA. Endoglycosidase- F, Protosol, and Omnifluor were
from New England Nuclear, Boston, MA, USA. Sodium dodecyl
sulphate (lauryl) was from Pierce Chemical Rockford,
Ill., USA. EDTA (ethylene diamine tetra acetate,
di-sodium salt), sodium dodecyl sulphate, D-sorbitol,
trichloacetic acid, and glycerol (extra pure) were from
Merck, Munchun, W. Germany. Sodium phosphate and ammonium
sulphate were from Riedel-de Haen, Seelze, Switzaland.
Adenosine, bovine serum albumin, dithiothreitol,
n-dibutylphthalate, deoxycholate (disodium salt), PPO,
Folin regent (2N), D-glucose, L-glucose, 3-0-methyl
glucose, heparin (sodium salt grade II), HEPES,
N,N'-methylene-bis-acrylamide, NBTGR, octyl glucoside
(n-octyl-j-D- glucopyranoside), PCMBS, PMSF, POPOP,
Sephadex G-50 (fine), inosine, cytochalasin B,
DEAE-cellulose DE-52, trypsin (type XIII), -chymo-
trypsin, thermolysin, leucine aminopeptidase
(microsomal), leucine aminopeptidase (cytosol), carboxy-
peptidase A, carboxypeptidase B, and carboxypeptidase Y
were from Sigma, St. Louis, MO, USA. All other reagents
were of analytical grade.


